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ABSTRACT
THE ENZYMATIC FUNCTION OF THE CCR4PROTEIN
By
JUNJICHEN 
University o f New Hampshire, May, 2001
The CCR4-NOT complex from Saccharomyces cerevisiae, which exists in two 
forms in vivo: 1.9 and l.OxlO6 MDa in size, is a general transcriptional regulatory 
complex. It regulates mRNA transcription in initiation, elongation and degradation.
The 1.0 MDa complex was purified to near homogeneity, and mass 
spectrometric analysis was used to identify all the components o f the complex. The
1.0 MDa complex contains CCR4, CAF1, NOT 1-5, and two new proteins, CAF40 and 
CAF130. CAJF130 and CAF40 are two unique yeast proteins, with CAF40 displaying 
extensive homology to proteins from other eukaryotes. Immunoprecipitation and gel 
filtration experiments confirm that CAE 130 and CAF40 are components o f both o f the 
1.9 MDa and 1.0 MDa CCR4-NOT complexes. Biochemical analysis indicated that 
the CAF40 and CAF130 proteins exist in peripheral position o f the complex. CAF130 
specifically interacted with both N- and C-terminal domains o f the NOT1 protein, 
suggesting that it lies adjacent to NOT1. Genetic analysis indicated that CAF40 and 
CAF13Q share few phenotypes with the rest o f the CCR4-NQT complex genes, 
consistent with the physical separation of CAF40 and CAF130 from the other proteins
x
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in the 1.0 MDa CCR4-NOT complex. CAF40 and CAF130, may, therefore play novel 
roles in the CCR4-NOT complex.
The CCR4 protein is an evolutionary conserved protein. The strongest 
conserved region o f the CCR4 protein lies in its C-terminal domain, which shows 
homology with the Mg2+ dependent nuclease family. In this research, we reported that 
the CCR4 protein indeed displayed 5' DNA/RNA phosphatase and 3'-5' exonuclease 
activities. First, we showed that GST-CCR4 (C-terminal domain) protein was able to 
bind only ssDNA and RNA. Second, we demonstrated that GST-CCR4 (C-terminal 
domain) protein possessed 5' DNA/RNA phosphatase and 3-5' exonuclease activities. 
Third, by using full-length CCR4-FLAG fusion protein, we found that CCR4 
displayed a 3’-5’ RNA poly (A) exoribonuclease and a poly (dA) ssDNA exonuclease 
activities, with preference for the RNA substrate. The CCR4 protein with the 
conserved catalytic residue mutations did not display all these activities. We propose 
that the regulatory effect o f the CCR4-NOT complex on gene expression may be 
executed through the CCR4 enzymatic function.
xi
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General Introduction
Regulation of gene expression is fundamental to biological systems. It touches 
almost everything in eukaryotic biology. It underlies development and differentiation. 
It is an endpoint of signal transduction pathways. It continually reshapes the cell in 
response to metabolic needs and environmental information. Most of the regulation of 
gene expression occurs at the level of transcription.
In eukaryotes, gene transcription by RNA polymerase II (RNA pol II) can be 
divided into three basic steps: transcription initiation, elongation and termination 
(reviews in Hampsey 1998; Holstege and Young 1999; Hirose and Manley 2000; 
Lemon and Tjian 2000). The initiation step is generally recognized as the following 
events: i). preinitiation complex assembly, during which general transcription factors 
(GTFs) assemble with RNA pol II at the promoter; ii). initiation, during which the 
RNA pol II holoenzyme, which includes core RNA pol H, mediators (SRBs) and some 
other general transcription factors such as TF1IH, TFIIE, TFEIF, synthesizes the first 
phosphodiester bond; iii). promoter clearance, during which RNA pol II holoenzyme 
leaves the promoter and the interactions with initiation-specific factors are disrupted. 
Transcription initiation requires several multiprotein complexes to be assembled and 
to functionally interact with each other to achieve efficient transcription. These 
multiprotein complexes include: the core RNA poly II holoenzyme complex that 
include the core transcription machinery which synthesizes nascent RNA from DNA
1
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templates; the TFUD complex that includes the TATA binding proteins (TBP) and its 
associated factors which recognize the TATA box of the promoter region; and other 
large complexes which aid transcription through chromatin such as the SAGA 
complex, which controls histone acetylation and transcription activation, and the 
chromatin-remodeling complexes including SWI/SNF and RSC-complexes which 
promote nucleosome disruption or displacement in an ATP dependent manner. The 
CCR4-NOT complex which represses diverse gene expression by destabilizing TBP 
association with non-canonical TATA element and activates transcription by unknown 
mechanisms (Badarinarayana et al 2000: Lemaire and Collart 2000).
During the transcript elongation phase, RNA pol II catalyzes successive 
polymerization o f nucleoside monophosphates into an oligoribonucleotide transcript 
based upon their complementarity to bases on a DNA template (review in Uptain et al 
1997). The elongation phase represents a dynamic process that the RNA pol II 
elongation complex navigates through chromatin and specific sequences that impede 
elongation. Numerous eukaryotic transcription elongation factors have been 
characterized by using biochemical in vitro assays and genetic in vivo assays (review 
in Wind et al 2000). There are at least two ways that factors stimulate elongation in 
vitro. One is to increase the average elongation rate in a DNA sequence-independent 
manner. The elongator complex is representative o f this group. One o f its 
components, ELP3, which is a histone acetyltransferase (HAT), can remodel and 
modify chromatin so that the RNA pol II overcomes repressive chromatin structures 
(Otero et al 1999). The other is to enable RNA pol II to generate long RNAs from 
short species after it has been arrested in a template-engaged but inactive state, or
2
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before it terminates transcription and is released from DNA. PTEF-b and SII (also 
known as TFIIS) are two representative factors in this category. PTEF-b has been 
shown to be a cyclin-CDK. complex, whose kinase target is the C-terminal domain 
(CTD) of the largest subunit o f RNA pol II (review in Price 2000). The CTD becomes 
extensively phosphorylated during the transition from initiation to elongation and 
remains phosphorylated during elongation. CTD phosphorylation had been found to 
be a prerequisite for the successful completion o f transcription. PTEF-b alleviates the 
negative effect o f DSIF, a negative elongation factor. The yeast homologs of DSIF, 
SPT5 and SPT4, form a complex that binds to RNA pol II and regulates elongation 
negatively. The SPT4, SPT5 proteins, and their related protein SPT6 were found in 
the establishment or maintenance o f chromatin states necessary for diverse 
chromosomal functions. TFIIS facilitates RNA polymerase II passage through arrest 
sites by stimulating an intrinsic ribonuclease activity of the polymerase and causing 
cleavage o f the nascent transcript near the 3’ end (review in Wind and Reines 2000). 
The CCR4 and CAF1 proteins, the only known suppressors of the spt6 mutation also 
display functions linked to transcription elongation (Denis et al 2001; Cui et al 2001; 
Chiang et al 2001).
Transcription termination is the process by which RNA pol II releases the 
nascent mRNA transcripts, dissociates from the DNA template, and recycles into the 
preinitiation state for the next round of transcription. Little is known about the details 
in the process o f termination. However, recent evidence suggests that a functional 
polyadenylation signal is required for RNA pol II to terminate transcription. After 
RNA pol II passes the poly (A) site (AATAAA), polyadenylation factors (in
3
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mammalian cells CPSF, CstF, CFI and poly (A) polymerase), and the CTD form a 
functional complex on the pre-mRNA to catalyze endonucleolytic cleavage (review in 
Hirose and Manley 2000). In many cases, there may be a lag in processing until RNA 
pol II encounters a pause site, which facilitates 3’ cleavage that in turn signals the 
RNA pol II to terminate and the complex to dissociate. The pause site can enhance 
polyadenylation in a coupled processing with transcription elongation factors release. 
FCP1, the apparent CTD phosphatase, dephosphorylates the CTD to allow reinitiation 
and the next round o f transcription (Cho et al 1999).
The CCR4 protein from S. cerevisiae is an evolutionarily conserved protein, 
and has orthologs in all eukaryotic organisms. In yeast, the CCR4 protein has been 
identified in the CCR4-NOT protein complex, which exists in two forms in vivo: 1.0 
MDa and 1.9 MDa. The smaller core complex, which has been purified (Liu et al 
1998; Bai et al 1999; this dissertation), contains the following proteins: CCR4, CAF1, 
five NOT proteins (NOT1-NOT5), CAF40 and CAF130. The 1.9 MDa protein 
complex appears to contain the core CCR4-NOT proteins, and possibly several other 
proteins, such as DBF2, DHH1, CAF4, or CAF16 (Liu et al 1998, 2001). These 
proteins have been identified as likely components of the 1.9 MDa CCR4-NOT 
complex. The CCR4—NOT complex is a global transcription factor, affecting the 
expression o f genes involved in non-fermentative growth, cell wall integrity, metal ion 
sensitivity and cell cycle regulation (Denis 1984; Liu et al 1998). Previous studies 
indicated that there are distinct physical interactions within the 1.0 MDa CCR4-NOT 
complex. The molecular ordering within this core complex appears to be CCR4-CAF1- 
NOTl-other NOTs. CCR4 and CAF1 bind to a central region ofNOTl whereas NOT2
4
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and N0T5 bind to a C-terminal section of NOT1. NOT4 is peripheral to NOT2 and 
NOT5, and NOT3 appears to make contact to both C-and N-terminal parts of NOTl (Bai 
et al 1999). The CCR4 protein also had been identified in a PAF1-containing RNA pol 
II transcription complex (Chang et al 1999). The PAF1-RNA pol II complex appears 
to play a role in recombination and in the expression of genes involved in cell wall 
biosynthesis.
Genetic and functional analysis o f these proteins confirm that the 1.0 MDa 
CCR4-NOT complex can be subdivided into two groups which can display distinct 
functions at certain promoters: the CCR4/CAF1 subgroup and the NOTs subgroup. 
The NOTs genes were identified as mutations that enhanced Tc dependent HIS3 
expression in a strain that contains a defective GCN4 activator (Collart and Struhl 
1993). HIS3 transcription is promoted from two elements, TR that contains a 
canontical TATA and Tc that lacks a well-defined TATA sequence. TR, which 
responds to GCN4, results in transcription at the +12 site at HIS3. while Tc the 
constitutive TATA element, results in an RNA beginning at the +1 site, not mutations 
cause increased utilization of the +1 HIS3 transcription start site, presumably through 
increased utilization o f the Tc element. It has been shown that the NOT proteins limit 
TBP access or decrease TBP stabilization at non-canonical TATA sequences by 
interacting with TBP or through factors associated with TBP (Badarinarayana et al 
2000: Lemaire and Collart 2000). These results suggest that the NOT protein 
subgroup is a  global transcriptional repressor that targets the general transcription 
machinery, preferentially affecting basal, rather than activated transcription.
5
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The CCR4 and CAF1 proteins are defined as a separate subgroup of proteins 
from NOT proteins both functionally and physically (Bai et al 1999). The CCR4 and 
CAF1 proteins are also distinct from the other components of the complex in that both 
proteins contain putative nuclease domains.
The CCR4 protein is specifically required for increased transcription o f ADH2 
resulting from mutations in the spt6 and sptlO genes, and also is required for 
derepression o f ADH2 and other genes under non-fermentative growth conditions 
(Denis 1984). Biochemical studies in our lab have shown that the CCR4 protein 
contains three major domains (Draper et al 1994). The N-terminal region, which is 
rich in glutamines and asparagines, contain an activation domain that may interact 
with the transcriptional machinery. The central region of the protein (residues 350 to 
473) contains five tandem copies o f a leucine rich repeat (LRR) domain. This domain 
has been shown to interact with CAF1 and other components o f the CCR4-NOT 
complex, and to be important to maintain the integrity of the CCR4-NOT complex. 
Bioinformatic studies showed that the C-terminal region o f the CCR4 protein 
displayed homology to apurinic endonucleases (details see Chapter II). Apurinic 
endonucleases are a group of critical enzymes that maintain the genome integrity 
against the spontaneous arisal o f abasic (AP) sites. Three representative AP 
endonucleases in this homologous family are Exonuclease III from E. coli; APE1 
(HAP1) from human; APN2 from yeast S. cerevisiae. Exonuclease III was first 
discovered in E. coli as an exonuclease and 3’-phosphatase and hence was shown to 
possess an AP endonuclease activity that was nearly equivalent to its exonuclease 
activity. Exo III represents ~90% o f the total AP endonuclease activity in
6
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exponentially growth E.coli. The major AP endonuclease in human cells is the HAP1 
(APE1) protein, which shows strong sequence similarity to Exo III (27% sequence 
identity, and 58% similarity).
All o f these apurinic nuclease proteins share five highly conserved motifs as 
follows: I: SYNTL, II: CLQE, III: GDFN, IV: IDYI and V: PSDH (Chapter II, Figure 
1 A). Based on the crystal structures o f both Exo III and HAP1 (APE1), each o f these 
motifs is the component of the critical conserved regions of the nuclease domain. For 
APE1, the aspartate and hisidine residues in the respective motifs IV and V make a 
direct hydrogen bond with the target AP site 5'-phosphate. Phosphodiester bond 
cleavage is achieved by hydroxyl nucleophile attack by the aspartate residue in motif 
III. This aspartate residue is correctly oriented by hydrogen bonds from the 
asparagine residue in motif I. The metal ion binding motif II utilizes a glutamic acid 
residue to bind a Mg 2+ion, stabilize the transition state and facilitate the OFT leaving 
group (Mol et al 2000). The C-terminal domain of the CCR4 protein contains all five 
conserved motifs and all the critical amino acids (Chapter II, Results).
Dlakic independently discovered that the CCR4 protein belonged to this family 
o f Mg2+ -dependent endonucleases and a divergent set of proteins that include 
phosphatases and sphingomyelinases (Dlakic et al 2000). He identified this nuclease 
family as including DNase I, Exo III, APE1 (HAP1), APN2, CCR4, the Line LI 
retrotransposon, noctumin, inositol polyphosphate 5-phosphatase, and 
sphingomyelinase. The alignment of representative sequences showed striking 
conservation o f catalytic residues o f AP endonucleases (motif IV and V). Moreover, 
the residues that bind Mg2+ (motif II), and the one that surrounds the catalytic pocket
7
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and possibly binds the phosphate were also conserved (motif I, III). Based on this 
evidence, the CCR4 appears to be a  putative nuclease.
The CAF1 protein, which is tightly associated with CCR4, is also required for 
glucose derepression o f gene expression (Draper et al 1995; Hata et al 1998). The 
yeast CAFI protein has orthologs in other eukaryotics such as M. musculus and C. 
elegans. The latter two proteins have been shown to contain a putative exonuclease 
domain (3’-5’ exoribonuclease or/and 3’-5’ exodeoxyribonuclease) by hidden Markov 
model (MMV) and phylogenetic studies (Moser et al 1997). This evidence postulated 
that yeast CAF1 possesses an extremely divergent exonuclease domain that has a 
tertiary structure and /or activity similar to that in metazoan CAF1 (Moser et al 1997).
The possible functional relation of CCR4 and CAFl to RNA endo or 
exonuclease activity is supported by analysis of DHH1, a muilticopy suppressor o f 
the cafl mutation. DHH1 is a putative evolutionarily highly conserved RNA helicase 
(Hata et al 1998). Overexpression o f DHH1 suppressed ccr4 or cafl defects, and a 
dhhl deletion resulted in similar cell wall defects as observed for ccr4. cafl and dbf2 
deletions (Hata et al 1998; unpublished observation). Most recently, through a 
comprehensive two-hybrid analysis o f protein-protein interactions in yeast genome 
(Uetz et al 2000), DHH1 has been found to be associated with DCP2, which is one of 
the components o f the decapping enzyme complex of mRNA (Dunckley et al 1999). 
DHH1 was subsequently found out to be another component of this decapping enzyme 
complex (Tucker et al 2001; R. Parker personal communication).
The first direct physical evidence o f  CCR4 and CAF1 enzymatic activities was 
derived from our collaboration with the Parker lab demonstrating that CCR4 and
8
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CAF1 are components o f the major cytoplasmic mRNA deadenylase in S. cerevisiae 
(Tucker et al 2001). Tucker and coworkers clearly established that CCR4 and CAF1 
are required for deadenylase activity. ccr4 and cafl strains showed defects in both the 
rate and extent o f deadenylation for the MFA2pG, PGKlpG, GAL 10, and RPL41A 
mRNAs. A ccr4 deletion together with pan2 (another known deadenylase) deletion 
strain completely blocked the deadenylation process, indicating that these two genes 
combine most if  not all o f the deadenylaase activity in yeast. Further, FLAG-CAF1 
copurified with a poly (A)-specific deadenylase activity. This activity required the 
presence o f the CCR4 protein. However, they were not able to identify the catalytic 
subunit and other factors involved in this process. The work presented in this 
dissertation resolves these issues.
NOT4 is another protein in the core CCR4-NOT complex involved in 
RNA/DNA metabolism. NOT4 residues 138-223 share homology to the RNP RNA 
binding motifs found in RNA binding proteins (Burd and Dreyfuss 1994). A typical 
RNP-RNA binding motif contains 80-90 amino acids with two highly conserved 
sequences, the RNP-1 octapeptide and the RNP-2 hexapeptides. The RNP-1 and 
RNP-2 motifs are located in two adjacent p-strands, and conserved amino acids within 
these motifs have been shown to be implicated in direct nucleotide contacts. From the 
predicted secondary structure using DNA Star and other bioinformatic programs, the 
NOT4 protein has almost the same structure as the RNP1 and RNP2. To ascertain 
whether NOT4 is an RNA binding protein, mutations and deletions were made in the 
NOT4 putative RNA binding motif. The mutation or deletion of the NOT4 RNA 
binding domain blocked the normal function o f the NOT4 protein. For instance,
9
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expression o f the deleted NOT4 or the Y194A, Y197A-NOT4 (highly conserved 
amino acids) version failed to complement the temperature sensitive phenotype of 
not4. although both proteins were adequately expressed in the cell (unpublished 
observations). These results suggest that the putative RNA binding m otif o f NOT4 is 
important to its function.
The focus o f this dissertation is to characterize the components and interactions 
o f the evolutionarily conserved CCR4-NOT protein complex, and to define the 
mechanisms by which the CCR4-NOT complex exerts control over transcriptional 
processes. The approaches taken to address this question were two fold:
1. Isolate and characterize the 1.0 MDa CCR4-NOT complex, identify and analyze the 
components o f this core CCR4-NOT complex. Previously, we partially purified the 
core 1.0 MDa CCR4-NOT complex, and identified most o f the components o f the 
complex (Liu et al 1998; Bai et al 1999). In this dissertation, I extended our research 
to purify the core CCR4-NOT complex to near homogeneity. CAF130 and CAF40 
were identified as two new components o f the complex. We further characterized 
these two new components inside the CCR4-NOT complex. This study is presented in 
Chapter I, and had been submitted for publication.
2. Analyze the roles of DNA or RNA binding and nuclease activities for CCR4 protein 
in its control o f  gene expression. Since the CCR4 protein contains a putative nuclease 
domain, I analyzed whether CCR4 displays DNA/RNA associated enzymatic 
activities. We collaborated with Dr. Roy Parker and demonstrated that CCR4 and 
CAF1 are components o f the cytoplasmic deadenylase complex involved in 
controlling mRNA degradation. This work has been published, and the manuscript
10
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can be found in the Appendix. We have further established that CCR4 is a 3’ ssDNase 
and RNase with a preference to poly (A) substrates. This study is presented in 
Chapter II.
11
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Chapter I
PURIFICATION AND CHARACTERIZATION OF THE 1.0 MDA CCR4-NOT 
COMPLEX IDENTIFIES TWO NOVEL COMPONENTS OF THE COMPLEX
Introduction
In Saccharomyces cerevisiae, the regulation o f gene transcription by RNA pol 
II is generally recognized as resulting from the interaction of several multiprotein 
complexes. These multiprotein complexes include the core RNA pol II holoenzyme 
complex, TFIID, the SAGA complex and the chromatin-remodeling complexes such 
as SWI/SNF and RSC. The CCR4-NOT complex is another important and 
evolutionarily conserved protein complex involved in regulating transcription and 
does so both positively and negatively (Collart and Struhl 1994; Liu et al 1998). This 
complex has been implicated in multiple roles in the control o f mRNA metabolism, 
including initiation (Denis and Malvar 1990; Sakai et al 1992; Collart and Struhl 
1993), elongation (Denis et al 2001), and mRNA degradation (Tucker et al 2001). 
Some of the genes it affects are involved in non-fermentative growth, cell wall 
integrity, metal ion sensitivity and cell-cycle regulation (Denis 1984; Liu et al 1997, 
1998; Chang et al 1999). The repressive effects o f the complex have been shown to 
result in part from restricting TBP access to non-canonical TATA sequences (Collart 
and Struhl 1994; Collart 1996), apparently through contacts made to TFIID
12
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(Badrinarayana et al 2000; Lee et al 1998; Lemaire and Collart 2000), and also in part 
from controlling the rate o f deadenylation o f mRNA (Tucker et al 2001). However, 
control o f other genes such as ADH2 does not involve repression, suggesting other 
modes o f action and protein contacts made by the CCR4-NOT complex. These might 
include interactions with SAGA components (Benson et al 1998) and the SRB9-11 
subset o f proteins from the RNA polymerase II holoenzyme (Liu et al 2001).
The CCR4-NOT complex exists in two forms in vivo, 1.9 and 1.0 MDa in size. 
The smaller core complex contains CCR4, CAF1, the five NOT proteins (NOT1-5) 
and other unidentified proteins (Draper et al 1995; Liu et al 1998). Previous studies 
indicated that there are distinct physical interactions within the 1.0 MDa CCR4-NOT 
complex (Bai et al 1999). The molecular ordering within this core complex appears to 
be CCR4-CAF1-NOT 1-other NOTs. CCR4 and CAF1 bind to a central region of 
NOT1 whereas NOT2 and NOT5 bind to a C-terminal section o f NOT1. NOT4 is 
peripheral to NOT2 and NOT5, and NOT3 appears to make contact to both C-and N- 
terminal parts o f NOT1. The 1.9 MDa complex in turn appears to contain the core 
CCR4-NOT proteins, and other proteins such as DBF2, CAF4, and CAP 16 (Liu et al 
1997, 2001).
In order to begin to understand the full extent o f the physical interactions and 
functional contacts made by the CCR4-NOT complex, all the components o f the 
CCR4-NOT complex need to be characterized. We report here the purification to near 
homogeneity o f the 1.0 MDa core CCR4-NOT complex. Using mass spectrometry, 
we have shown that it contains the following proteins: CCR4, CAF1, NOT1-5, and 
two new proteins, CAF130 and CAF40. CAF130 and CAF40 are two unique yeast
13
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proteins and were localized to a part of the 1.0 MDa CCR4-NOT complex that is 
separate from that o f the CCR4 and CAF1 proteins and the NOT2, NOT4 and NOT5 
proteins. The different location and lack o f shared phenotypes with other components 
o f  the complex suggest they play novel roles in the complex.
This work was accomplished by cooperation with numerous researchers in Dr. 
Clyde. L. Denis’s lab and in Dr. Matthias Mann’s lab. Specifically, the purification of 
the CCR4-NOT complex was achieved by cooperation with Yueh-Chin Chiang in our 
lab. The mass spectrometry analysis was done by Juri Rappsilber and Matthias Mann 
in Protein Interaction Laboratory from University o f Southern Denmark. One of the 
Superose 6 gel filtration analysis of the CAF130 and CAF40 protein (Figure 2) was 
kindly provided by Pam Russell from our lab. The genetic analysis o f the caf!30 and 
caf40 was partially provided by Dr. Clyde L. Denis. I deeply appreciated their 
contribution to this project.
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Materials and Methods
Yeast strains, growth conditions, and enzyme assays
Yeast strains (Table 1) were grown at 30°C on YEP medium (2% yeast extract, 
1% Bacto Peptone) or selective medium (Draper et al 1994) supplemented with either 
4% glucose or 2% galactose/2% raffinose unless otherwise indicated. (3-galactosidase 
and alcohol dehydrogenase (ADH) assays were carried out as described previously 
(Bai et al 1999). Assay values represent the average of at least three independent 
determinations. Deletion strains were obtained using standard yeast procedures with 
the appropriate DNA constructs described below.
Purification of the CCR4-NQT complex and protein identification bv mass 
spectrometry
Purification o f the CCR4-NOT complex was done as described previously (Liu 
et al 1998) according to the scheme presented in Figure 1A. Following SDS-PAGE, 
proteins were visualized by Coomassie Blue staining and identified by MALDI and 
nano ES triple quadrupole mass spectrometry as described previously (Wilm et al 
1996; Shevchenko et al 1996; Liu et al 1998).
Gel filtration chromatography
Gel filtration chromatography was carried out as previously described with a 
few modifications (Liu et al 1998; Bai et al 1999). Yeast whole cell extracts prepared 
from 1 L yeast culture in 3X buffer A plus protease inhibitors were clarified by 
ultracentrifugation at 100,000g for 5 min. After clarification, 200 |il o f the extracts 
were loaded onto a Superose 6 10/30 column with running buffer G (50 mM Tris- 
OAc, pH7.9/ 150 mM KOAc/ 10% glycerol). The calibration of the Superose 6 HR
15
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10/30 column was: blue dextran (2.0 MDa) at 10 ml; thyroglobulin (0.67 MDa) at 15 
ml; bovine serum albumin (66 KDa) at 17 ml. The Mono Q fractions containing 
CCR4 material were directly loaded onto the Superose 6 column using the same buffer 
A.
DNA constructions
All DNA manipulations utilized the standard protocols. The full length of 
CAF40 (YNL288w) and CAF130 (YGR134w) ORFs were cloned by PCR from yeast 
genome using Yeast GenePairs ™ from Research Genetics™ using Pfu DNA 
polymerase. The CAF40 and CAF130 sequences were further confirmed by DNA 
sequencing. The EcoRI-Smal pieces o f the CAF40 and CAF130 PCR products were 
cloned into SP72 or pBluescript vector as pJCN59 or pJCN64 respectively. The 
EcoRI-Sall piece o f full length CAF40 from pJCN59 was then fused with LexA202,
B42 and GST in plasmids LexA202-4, pJG4-5, pGEX-KG respectively (Cook et al 
1994; Chiang et al 1996). The EcoRI-BamHI fragment o f full length CAF130 from 
pJCN64 was similarily fused with LexA202, B42, and GST, respectively. The CAF40 
gene disruption was made by placing the BamHI fragment o f the URA3 gene from 
pJH633 into pJCN59 cut with Mfel piece. This removed amino acids residues from 
111 to 363 o f  CAF40. The CAF130 deletion was made by replacing the Bgll 
fragment o f pJCN64 with the BamHI piece o f the URA3 gene from pJH633. This 
resulted in a CAF130 protein missing residues from 52 to 892. The chromosomal 
gene disruptions were made by cutting the CAF4Q and CAF130 disruptions with 
EcoRI and BamHI, and transforming yeast using standard protocols. The CAF130 
and CAF40 disruptions were then confirmed by both PCR using Yeast GenePairs ™
16
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from Research Genetics™ and Western blot using anti-CAF130 and CAF40 
antibodies respectively.
Western analysis and Immunoprecipitation
Western analysis was conducted as described previously (Liu et al 1998). 
Immunoprecipitations were performed as described in detail elsewhere (Liu et al
1997). Silver and Coomassie staining of proteins were carried out using standard 
procedures (Draper et al 1994).
17
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Table 1 Yeast Stains
Strain Genotype
EGY191 MATccura3 his3 trpl LexA-LEU2
MLF6 Isogenic to EGY191 except cafl::LEU2 trp I::CAFl-6His-TRP 1
EGY188 MATa ura3 his3 trpl LexA-LEU2
EG Y 188-la Isogenic to EGY188 except ccr4::URA3
EG Y188-c 130-UL-A1 Isogenic to EGY188 except cafl30:::ura3::LEU2 adhl::URA3
FCY803 MATa Ieu2-PET56 trpl-1 ura3-52 gal2 gcn4-l
KY803-1 Isogenic to K.Y803 except ccr4::URA3
K.Y803-CI Isogenic to KY803 except cafl::LEU2
MY8 Isogenic to K.Y803 except not 1-2
MY508 Isogenic to K.Y803 except not3::URA3
M Y537 Isogenic to KY803 except not4::URA3
MY 1735 Isogenic to KY803 except not5::URA3
KY803-C130 Isogenic to KY803 except cafl30::URA3
KY803-c40 Isogenic to KY803 except caf40::URA3
K Y803-c40-UL-Al Isogenic toKY803 except ca/40::ura3::LEU2 adhl::URA3
1279-4a MATa ura3 his3 leu2 trpl sptlO::TRPl
DY3462 MATa his4-9128his4-9128-ADE2 Iys2-I288canl leu2 ura3
DY3462-c40 Isogenic to DY3462 except caf40::URA3
DY3462-C130 Isogenic to DY3462 except cafl30::URA3
FY1642 MATa his4-9128lys2-1288leu2Al ura3-52 SPT5-FLAG
FY1635 c40 MATa his4-9128lys2-1288leu2Al ura3-52 spt5-242 caf40::URA3
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Results
Purification of the 1.0 MDa CCR4-NOT complex.
We have previously shown that the 1.0 MDa CCR4-NOT complex contains 
CCR4, CAF1, and five NOT proteins (NOT1-5) (Liu et al 1998; Bai et al 1999). In 
order to identify other components o f the 1.0 MDa CCR4-NOT complex, we carried 
out a series o f standard chromatographic procedures to purify the complex following 
the scheme summarized in Figure 1A. We isolated the CCR4-NOT protein complex 
from a strain carrying a single integrated copy o f CAF1 tagged at its C-terminus with 
6His (Liu et al 1998). Following passage o f yeast extracts over a Ni^-agarose affinity 
column, the CCR4-NOT complex was subjected to Mono Q column chromatography 
and was found to elute at both 0.4 M and 1.2 M KOAc as monitored with anti-CCR4 
antibody. The composition o f the proteins in the CCR4-NOT complex for these two 
peaks was found to be identical (data not shown) and the 1.2 M KOAc fraction was 
used for further analysis. The Mono Q fractions containing the CCR4-NOT complex 
were subjected to Superose 6 gel-filtration chromatography and the CCR4-NOT 
complex was found to migrate at about 0.9 MDa (Figure IB). To further purify the 
CCR4-NOT complex, the Mono Q fractions were immunoprecipitated with either anti- 
CCR4 antibody or with control anti-LexA-antibody. Following SDS-PAGE, the 
components o f the immunoprecipitated complex were detected by Coomassie Blue 
staining (Figure 1C).
19
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About fifteen unique protein species were identified in the CCR4 
immunoprecipitated materials as compared to the LexA immunoprecipitated materials 
(compare lane 2 to 1, Figure 1C). All protein bands were excised from the gel, and the 
proteins were identified by mass spectrometry (Liu et al 1998). Several o f the proteins 
bands were obviously contaminant protein bands as they were present in both the 
LexA and CCR4 immunoprecipitation and most of these were identified as human oc- 
keratin or protein A (also see legend to Figure 1C).
All o f the previously identified components o f the core CCR4-NOT complex 
were identified by this purification procedure, except for the NOT3 protein. We have 
previously demonstrated that NOT3 appears to be less stably associated with the 
CCR4-NOT complex and can be more easily dissociated from it than other 
components (Bai et al 1999). Our mass spectrometric analysis may also have missed 
detecting it as CAF130 was identified at the same location (see below). Based on our 
previous data that NOT3 can co-immunoprecipitate with the other factors present in 
the 1.0 MDa CCR4-NOT complex (Liu et al 1998; Bai et al 1999), we believe that 
NOT3 protein is indeed one of the components in the CCR4-NOT complex. Also, in 
crude extracts NOT3 migrates in 1.9 MDa and 1.0 MDa size complexes coincident 
with CCR4 (see Figure 2). It should also be noted that multiple protein species for 
CAF1, NOT4 and NOT5 were identified, suggesting that these proteins are post- 
translationally modified. NOT5 (M. Collart, personal communication) and CAF1 (A. 
Sakai, personal communication) are known to be phosphorylated proteins.
20
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Figure 1A
Purification of the 1.0 MDa CCR4-NOT Complex
140 g of wet yeast cells
i
4 ml Ni 2+ -NTA, agarose
250 mM imidazole elution 
Mono Q HR/5
1.2 M KOAc fraction
0.4 M KOAc fraction centricon-10 concentrated
I




A. Purification scheme utilized for isolating the CCR4-NOT complex. The 0.4 M KOAc 
fractions containing CCR4-NOT proteins appeared identical to that o f the 1.2 M KOAc 
fractions by both Superose 6 chromatography and CCR4 immunoprecipitation.
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B. Superose 6 chromatographic profile o f 1.2 M KOAc Mono Q fractions. Superose 6 
gel permeation chromatography was conducted as described previously (Bai et al 1999). 
The markers used for standardizing the column were blue dextran (2.0 MDa), 
thyroglobulin (0.67 MDa), and bovine serum albumin (0.066 MDa). Western analyses 
were done with antibody directed against NOT1, CAF130, CCR4 and CAF40.
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C. Coomassie stained proteins in purified CCR4-NOT complex. The 1.2 M KOAc 
fractions following Mono Q chromatography were immunoprecipitated with either anti- 
LexA or anti-CCR4 antibodies. Following SDS-PAGE, the proteins were stained with 
Coomassie Blue immunoprecipitation, albeit to a lesser degree. All other Coomassie 
stained bands were found to be artefacts, either alpha-keratins or protein A agarose, 
except for the 210 kDa species above NOT1 which was URA2, a 53 kDa band above the 
IgG that contained a degradation fragment of CCR4 and the 36 kDa band below CAF40 
which ILV6 and SNF4 were identified. We have no other evidence for either ILV6 or 
SNF4 as proteins being in the CCR4-NOT complex.prior to being excised and analyzed 
by mass spectrometry (Shevchenko et a ll996; Wilm et al 1996). CAF120 refers to a 
protein that was also present in the LexA
23
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CAF130 and CAF40 are two new unique yeast proteins present in the CCR4- 
NOT complex
In addition to the known components o f the CCR4-NOT complex, two 
previously unknown proteins were identified that were present in the CCR4 
immunoprecipitates but which were not present in the LexA immunoprecipitates:
CAP 130 (yGR134w) and CAF40 (yNL288w) (Figure 1C). When the Mono Q pooled 
fractions were sized by gel-filtration chromatography, both CAF130 and CAF40 were 
found to migrate at the same 0.9 MDa size as other members o f the complex (Figure 
1B), suggesting that these two proteins were indeed part o f the 1.0 MDa CCR4-NOT 
complex.
Database analysis showed that CAF130 is a unique yeast protein which does 
not share any homology to any other known protein. CAF40, while a unique protein 
in S. ceresiviae, displayed extensive homology to the S. pombe RCD1 protein 
(Okazaki et al 1998). RCD1 plays a role in controlling sexual development induced 
by nitrogen starvation in S. pombe (Okazaki et al 1998). Both RCD1 and CAF40 
share more than 70% homology within their conserved regions (residues 110 to 373 of 
C AF40) with proteins from Arabidopsis, C. elegans, and Homo sapiens (Okazaki et al
1998).
24
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CAF40 and CAF130 proteins are components of the 1.0 and 1.9 MDa CCR4- 
NOT complexes.
The above results indicate that CAF130 and CAF40 copurify with the 1.0 MDa 
CCR4-NOT complex. Immunoprecipitations were performed in CCR4 wild-type and 
ccr4 deletion strain backgrounds using antibodies against CCR4 to establish that the 
CAF40 and CAF130 proteins were not fortuitiously immunoprecipitating with anti- 
CCR4 antibody. As shown in Figure 3, both CAF130 and CAF40 could co- 
immunoprecipitate with CCR4, while in the ccr4 deletion strain CAF130 and CAF40 
were not found to be associated with CCR4 (compare lane 3 to lane 4). This result 
clearly demonstrates that CAF130 and CAF40 proteins associate with the CCR4-NOT 
complex.
To further determine if CAF130 and CAF40 were components o f  both the 1.0 
and 1.9 MDa CCR4-NOT complexes, we examined CAF130 and CAF40 migration 
following Superose 6 gel-filtration chromatography as shown in Figure 2. CAF130 
and CAF40 proteins co-migrated in the same positions as other CCR4-NOT 
components and in complexes that were 1.9 and 1.0 MDa in size.
Although the stochiometric ratio o f each component in the purified complex is 
not known, the total molecular weight o f this complex adds up to about 0.9 MDa 
based on the size o f each component’s monomeric molecular weight. This value 
strongly agrees with the estimated size o f the core CCR4-NOT complex as 0.9 to 1.0 
MDa (Liu et al 1998; Bai et al 1999). Based on the above results, we believe that we 
have identified all o f the components o f the 1.0 MDa core CCR4-NOT complex and
25
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have established that CAP 130 and CAP40 are integral components of both the 1.0 and
1.9 MDa CCR4-NOT protein complexes.
26
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Figure 2. CAF40 and CAF130 migrate in 1.9 and 1.0 MDa complexes
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Superose 6 gel chromatography and yeast crude extracts and western analysis was 
conducted as described in Figure IB. Yeast Crude extract were prepared from strain KY 
803. (These data were kindly provided by P. Russell)
27
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CCR4 immunoprecipitations were conducted in strains EGY188 (WT, lanes 1 and 3) or 
EGY188-la fccr4. lanes 2 and 4) as previously described (Liu et al 1998). Western 
analysis was conducted with antibodies directed against the proteins as indicated. Lanes 
1 and 2- crude extracts; lanes 3 and 4- CCR4 immunoprecipitates.
28
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CAF130 and CAF40 are peripheral components of the CCR4-NOT complex.
We have previously proposed a model o f  the molecular arrangement o f the 
components o f the 1.0 MDa CCR4-NOT complex (Bai et al 1999). In this model, 
CCR4 and CAF1 bind to the central region o f NOT 1, whereas NOT2, NOT4, and 
NOT5 associate with the C-terminus o f NOT1. In addition, CAF1 is required for 
CCR4 to associate with the rest of the complex (Liu et al 1998). To identify the 
location o f CAF130 and CAF40 in this complex, we carried out two sets o f 
experiments.
First, immunoprecipitations were performed using antibodies against CCR4 
and CAF1 to determine which components o f  the CCR4-NOT complex associated 
with the CAF130 and CAF40 proteins. As shown in Figure 4A using anti-CCR4 
antibody, CCR4 could not co-immunoprecipitate CAF130 and CAF40 in a cafl 
deletion strain, while CCR4 was able to associate with CAF130 and CAF40 in a 
CAF1 wild type strain (lane 4 compared to lane 3). This result indicates that CAF130 
and CAF40 are positioned on the other side o f CAF1 away from CCR4. We 
subsequently examined the relative location of CAF130 and CAF40 to the NOT 
proteins using mutations or deletions in the NOT genes. In the not 1-2 strain which 
expresses primarily a 1-1100 amino acid form o f  the NOT1 protein (Bai et al 1999; 
Maillet et al 2000), CAF1 was capable of immunoprecipitating CAF130 and CAF40 
(Figure 4B, compare lane 2 to lane 1). Because NOT2, NOT4, NOT5 association with 
CAF1 is disrupted in a not 1-2 background (Bai et al 1999), CAF130 and CAF40 must 
be able to associate with CAF1 through the N-terminal 1100 residues ofN O T l. This
29
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observation is supported by the results with not3. not4 and notS deletions. In each 
case CAF130 and CAF40 were capable o f immunoprecipitation with CAF1 even when 
NQT3. NOT4 or NOT5 were deleted (Figure 4B, compare lanes 3, 4, 5 to lane 1). 
These results locate CAF130 and CAF40 with CAF1 and to the N-terminal 1100 
residues ofN O T l.
Second, we examined whether caf!30 and caf40 deletions have any impact on 
the formation o f the CCR4-NOT complex. We carried out a CCR4 
immunoprecipitation in a wild-type strain and in a strain carrying either a caf!30 or 
caf40 deletion. As are shown in Figure 5, CCR4 was able to co-immunoprecipitate all 
the known components o f the CCR4-NOT complex (CCR4, CAF1, NOT 1-5) in 
strains carrying either a caf!30 or caf40 deletion (compare lanes 5 and 6 to lane 4). 
Similarly, using anti-NOTl antibody to conduct immunoprecipitation, the caf40 and 
caf!30 deletions had no effect on the ability of any CCR4-NOT proteins 
immunoprecipitationg with NOT1 (data not shown). These results indicate that 
CAF130 and CAF40 are not components critical to the formation of the CCR4-NOT 
complex and suggest that CAF130 and CAF40 are two peripheral components o f the 
CCR4-NOT complex.
30
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Figure 4. cafl. notl-2. not3. not4. and not5 effects on CAF40 and CAF130
association with the CCR4-NOT complex.
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A. CAF1 is required for CAF40 and CAF130 to associate with CCR4. CCR4
immunoprecipitations and western analyses were conducted as described in Figure 3 
using strains EGY188 (WT, lanes 1 and 3) and EGY188-cl ('cafl. lanes 2 and 4). Crude 
extracts- lanes 1 and 2; CCR4 immunoprecipitates- lanes 3 and 4.
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B. Defects in the N0T1, NOT3, NOT4 and NOT5 proteins do not affect CAF40 and 
CAP 130 association with the CCR4-NOT complex. Immunoprecipitations and western 
analyses were conducted as described above using strains K.Y803 (WT, lane 1), MY8 
fnotl-2. lane 2), MY508 fnot3. lane 3), MY537 (not4. lane 4), and MY1735 fnot5. lane 
5).
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Figure 5. caf40 and caf!30 deletions do not affect the formation of the CCR4-
NOT complex.
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Immunoprecipitations and western analyses were conducted as described in Figure 3
using strains EGYI88 (WT, lanes 1 and 4), EGY188-cl30 f cafl 30. lanes 2 and 5), and
KY803-c40 (caf40. lanes 3 and 6). Crude extracts- lanes 1-3; CCR4
immunoprecipitates- lanes 4-6.
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CAF130 interacts with both N-terminal and C-terminal regions of the NOT1 
protein
In order to further localize CAF130 and CAF40, we used yeast two-hybrid 
analysis to examine interactions between these proteins and all the known components 
o f the 1.9 MDa and 1.0 MDa CCR4-NOT complexes. The results are summarized in 
Table 2. The only interaction we observed for B42-CAF40 was with LexA-NOTl 
(Table 2, line 2). LexA-CAF40, although a self-activator, also interacted with B42- 
DBF2, B42-SRB9 and B42-NOT4 (lines 7, 8, 9). DBF2 protein is tightly associated 
with CCR4, and may be a component of the 1.9 MDa CCR4-NOT complex (Liu et al 
1998, 2001) and SRB9 interacts with both o f the CCR4-NOT complexes (Liu et al 
2001).
CAF130, on the other hand, showed a strong two-hybrid interaction with the 
NOT1 protein (Table 2, lines 11-16). LexA-CAF130 interacted with both the N- 
terminal (1-1152) and C-terminal regions (1152-2108) o f B42-NOT1 (lines 13 and 
15). LexA-CAF130 also displayed weak interactions with B42-NOT4 and B42-NOT5 
(lines 17 and 18). Immunoprecipitation with anti-LexA antibody confirmed that 
LexA-CAF130 could coimmunoprecipitate with B42-N0T1( 1-667) ( Figure 6, lane 7), 
B42-NOT1 (1 -1152) (lane 6), B42-N0T1(1152-2108) (lane 9) and B42-NOT1(1-2109) 
(lane 8). Immunoprecipitation of LexA alone did not co-immunoprecipitate any of 
these B42-fusion proteins (data not shown) nor did LexA-CAF130 
immunoprecipitation of B42-CAF6 immunoprecipitate the B42-moiety (lane 10). 
CAF130 appears to be located adjacent to NOT1 and capable o f interacting with both
34
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N- and C-terminal portions of NOT1 whereas CAF40 is probably associated with 
NOT1.
Yeast CAF40 retains its ability to interact with human NOT1
The identification o f  orthologs for the CAF1 and NOT genes (Draper et al 
1995; Albert et al 2000) allowed us to determine if the interaction between CAF40 and 
NOT1 was evolutionarily conserved. We consequently analyzed the ability o f yeast 
CAF40 to interact in a two-hybrid assay with human NOT1 (hNOTl). As shown in 
Table 2, LexA-hNOTl displayed a significant two-hybrid interaction with B42- 
CAF40 (line 5). Since LexA-hNOTl has been shown to retain its ability to bind the 
human forms o f CAF1, NOT2 and NOT4, as well as the yeast forms of these proteins, 
we interpret our results to suggest that the human CAF40 protein (human RCD1) also 
interacts with hNOTl and would be part of the human CCR4-NOT complex. LexA- 
hNOTl did not, however interact with B42-CAF130 (data not shown).
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Table 2. Two-hybrid interactions of CAF40 and CAF130 with NOT protein
LexA fusion B42 Fusion P-Gal (U/mg) Line
LexA-NOTl B42 3.8 1
LexA-NOTl B42-CAF40 44 2
LexA-NOTl B42-CAF130 82 3
LexA-hNOTl B42 4.2 4
LexA-hNOTl B42-CAF40 700 5
LexA-CAF40 B42 380 6
LexA-CAF40 B42-DBF2 940 7
LexA-CAF40 B42-SRB9 1000 8
LexA-CAF40 B42-NOT4 820 9
LexA-CAF130 B42 2.1 10
LexA-CAF130 B42NOT1 ( 1-2108) 170 11
LexA-CAF130 B42 NOTl(l-667) 1500 12
LexA-CAF130 B42NOT1 (1-1152) 1300 13
LexA-CAF130 B42NOT1 (1-1480) 1700 14
LexA-CAF130 B42 N O Tl(l 152-2108) 1900 15
LexA-CAF130 B42-NOT4 120 16
LexA-CAF130 B42-NOT5 29 17
(Legend continue)
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LexA-CAF130, LexA-NOTl, LexA-CAF40, B42-NOT4, B42-NOT5, B42- 
CAF40, B42-CAF130 and B42-DBF2 contain full-length version of the respective 
proteins. LexA-hNOTl contains residues 1000-2376 of hNOTl, B42-SRB9 contains 
residues 367-1420 of SRB9, and B42-NOT1 fusions contain the residues o f NOT1 as 
indicated. All LexA proteins were LexA-( 1-202). P-galactosidose activities were 
determined in diploid EGY188/EGY191 containing the p34 reporter (8 LexA 
operators upstream of lacZ) following growth on minimal medium lacking uracil, 
tryptophan and histidine that contained 2% galactose/2% raffmose. Assays represent 
the average o f at least three transformants and standard error of the means (SEMs) 
were less than 20%.
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Figure 6. Both N- and C-terminal segments of NOT1 associate with LexA-CAF130.
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LexA immunoprecipitations and Western analysis using anti-HA 1 antibody were
conducted as described in Figure 3. Diploid strain EGY188/EGY191 was used for the
immunoprecipitations and contained LexA-CAF130 and the indicated B42-fiision
protein. The band marked with the asterisk was a contaminant band recognized by the
HA1 antibody.
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Analysis of phenotypes of caf40 and cafl30
We subsequently analyzed the physiological roles o f CAF40 and CAF130 by 
constructing deletions o f the corresponding genes in vivo. Neither gene was found to 
be essential. A number o f phenotypes typically associated with defects in CCR4-NOT 
components was examined and is summarized in Table 3. The only phenotype 
associated with caf!30 was that it resulted in a weak spt- phenotype. caf40. in turn, 
gave rise to a growth defect following growth at 41°C and displayed caffeine 
sensitivity. However, both these caf40 defects were observed in only some genetic 
backgrounds (data not shown). The observation that caf40 and caf!30 result in less 
severe phenotypes than defects in other CCR4-NOT components correlates with 
CAF40 and CAF130 proteins being in a separate part of the CCR4-NOT complex 
from CCR4 and CAF1 and from the NOT2, NOT4 and NOT5 proteins.
The caf40 and caf!30 deletions were also combined with deletions in other 
components o f the CCR4-NOT complex. It was observed that combining caf40 or 
cafl30 with either ccr4. cafl not4. or not5 produced no observable synthetic 
phenotypes (for example, temperature sensitivity, cold sensitivity, caffeine sensitivity, 
or growth defects on different carbon sources) (data not shown). This lack of 
synthetic interactions with defects in other CCR4-NOT components contrasts with the 
synthetic lethalities observed between ccr4 or cafl with that o f not2 or not5 (Bai et al
1999).
Defects in CCR4-NOT components affect the expression of a number o f genes 
(Collart and Struhl 1994; Denis 1984; Denis and Malvar 1990; Liu et al 1998). As 
summarized in Table 3, neither caf40 nor cafl 30 evinced a not phenotype (increased
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HIS3 expression in a gcn4 background), affected ADH2 derepression, or suppressed 
sptlO-enhanced expression. In addition, the effect o f caf40 or cafl 30 on different 
promoter-driven lacZ reporters showed only limited effects on the reporters analyzed 
fFKSl-lacZ. ADH2-lacZ. GALl-lacZ and HO-lacZf (data not shown) unlike the more 
severe effects observed on lacZ reporters with ccr4. cafl or not defects (Liu et al
1998). Together the above results indicate that CAF40 and CAF130, while 
components o f the CCR4-NOT complex, are not intimately involved in the key 
processes that have been characterized to date for this complex.
Because o f the homology of CAF40 to the R.CD1 protein from S. pombe, we 
also tested whether a caf40 deletion resulted in a defect in sporulation similar to that 
observed for rcdl homozygous diploids. caf40/caf40 diploids resulted in only 8% of 
diploids undergoing sporulation (data not shown). In contrast, 60% of the 
caf40/CAF40 diploids underwent sporulation. No effect on sporulation was observed, 
however, for cafl30/cafl30 diploids (data not shown).
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Spt+ ADH II ADH II
sptlO
WT + + + + + - + 3000 52
ccr4 + - + - - - + 500 23
caf40 + - + - - - + 3800 58
cafl 30 + + + + + - - 3100 55
Growth was monitored on YEP medium containing 2% glucose (YD), 3% 
glycerol (YGly), or 2% glucose with 8 mM caffeine (8 mM Caff) at the temperatures 
indicated. Spt+phenotypes were analyzed as described (Badarinarayana et al 2000). 
ADHII activities (mU/mg) were determined following growth on YEP medium with 
3% ethanol as previously described (Denis 1984), whereas ADH II sptlO activities 
were determined on YEP medium containing 8% glucose. Growth was monitored in 
segregants FY1642/FY16435-c40 fcaf40) or in EGY188, EGYl 88-la (ccr4), and 
EGY188-cl30 (cafl30). The Spt+ phenotype was determined in strains DY3462, -la  
(ccr4), -c40 (caf40), and -c l30 (cafl30). ADH II activities for caf40 and c a f l30 
strains were measured in strains KY803-c40-UL-Al and EGY188-cl30-UL-Al, 
respectively. ccr4 phenotypes and ADH II values were taken from Denis 1984 and 
Liu e ta l 1998. (continued)
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ADH II sptlO activities for wild-type (WT), caf40 and cafl30 were obtained from 
segregants o f  diploid l279-4a/KY803-c40-UL-Al and 1279-4a/EGY188-cl30-UL- 
Al. Values represent the average of at least four assays and standard errors o f the 
means were less than 20%. Growth o f other strains carrying caf40 (KY803 or 
DY3462 background) did not, however, elicit caffeine, glycerol, or temperature 
sensitive phenotypes.
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Discussion
In this study, we described the purification o f the 1.0 MDa CCR4-NOT 
complex from yeast. The core 1.0 MDa CCR4-NOT complex was shown to be 
composed o f CCR4, CAP1, NOT1-5, CAF130, and CAF40 based on mass 
spectrometric analysis of purified proteins, immunoprecipitation, and gel filtration 
analysis. The identification of these proteins agrees with previous data that had 
implicated seven o f the nine subunits as part o f the 1.0 MDa complex (Liu et al 1998; 
Bai et al 1999). The NOT3 protein, however, was not found to be part o f the purified 
complex by mass spectrometric analysis. At the molecular weight o f NOT3, the 
CAF130 was identified instead. It is possible that the NOT3 protein was missed by 
the mass spectrometric analysis or, alternatively, as was previous indicated, the NOT3 
protein may be more easily dissociated from the complex than the other components 
(Bai et al 1999). Several lines of evidence demonstrate that NOT3 is indeed one o f 
components o f the complex. First, NOT3 as well as the other four NOT genes have 
been the only genes identified which when mutated allow increased Tc-dependent 
HI S3 expression in a strain that lacks optimal GCN4 function (Collart and Struhl 
1993,1994). Second, the NOT3 protein comigrates in both the 1.9 and 1.0 MDa size 
complexes, the same size as all the other components o f the CCR4-NOT complex 
following gel filtration chromatography (Figure 2). Third, immunoprecipitating 
NOT3 co-immunoprecipitated all the other components o f the 1.0 MDa CCR4-NOT 
complex (Bai et al 1999; P. Russell, unpublished results).
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Our study has identified two previously unknown proteins CAF130 and 
CAF40 as integral components o f the CCR4-NOT complex. CAF130, unlike other 
components o f the CCR4-NOT complex, did not show any significant homology to 
any other protein. Although the physiological function o f  CAF130 is unknown, it can 
strongly interact with two separate regions o f the NOT1 protein as determined by two 
hybrid assays and immunoprecipitition. On the other hand, CAF40 showed strong 
homology to S. pombe RCD1 (Okazaki et al 1998). RCD1 is an evolutionary 
conserved protein throughout eukaryotes. Budding yeast, fission yeast, plants, worms 
and humans all contain an ROD 1-like protein and display over 70% identity in the 
core residues 110 to 373 of CAF40. The S. pombe RCD1 was found to be one o f the 
factors controlling the onset of sexual differentiation as well as to be important in 
transmitting the nitrogen starvation signal (Okazaki et al 1998). We also found that 
homozygeous caf40/caf40 diploids are defective in sporulation. Because of CAF40 
presence in the CCR4-NOT complex and the apparent conservation o f the CCR4-NOT 
complex in other eukaryotes (Draper et al 1995; Albert et al 2000), RCDl might be in
S. pombe a transcriptional target for the nitrogen starvation signal and signals 
regulating the onset o f  sexual development.
In the purified 1.0 MDa complex we have not been able to identify other 
proteins such as DHH1, CAF4, CAF16, DBF2, and MOB1, all of which have been 
found to associate with the CCR4-NOT proteins (Hata et al 1998; Liu et al 1997,
2001; Komanistsky et al 1998; Bai et al 1999). In addition, none of these proteins 
have been found to co-immunoprecipitate at their physiological concentrations with 
any other core CCR4-NOT complex components. We conclude, therefore, that these
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other proteins are not part o f the 1.0 MDa CCR4-NOT complex and may instead be 
components o f the 1.9 MDa complex. In support of this conclusion is the observation 
that CAF4, CAP16, DBF2 and MOB1 have been found to migrate in a complex whose 
size is 1.9 MDa (Liu et al 2001; unpublished observations). Moreover, CAF4 and 
CAP 16 fail to migrate at 1.9 MDa when the CCR4 gene is disrupted, suggesting that 
at least these two proteins are part o f the 1.9 MDa CCR4-NOT complex (Liu et al 
2001).
Based on the results we presented herein, we propose a modified model for the 
arrangement o f factors in the core 1.0 MD CCR4-NOT complex (Bai et al 1999) 
(Figure 7). Because o f the extremely strong two-hybrid interactions between CAF130 
and NOT1 and the lack of interactions between CAF130 and other components o f the 
core CCR4-NOT complex, CAF130 appears located adjacent to the NOT1 protein, 
with contacts to both N- and C-terminal portion of the NOT1 protein. In support of 
this location, we note that CAF130 association with NOT1 protein is independent of 
NOT2, NOT3, NOT4 and NOT5 association with the NOT1 protein. This suggests 
that CAF130 contacts different regions o f the NOT1 protein than these other factors 
are interacting with. This also means that CAF130 binds a different region o f the C- 
terminus of NOT1 than the other NOT proteins bind to. We were not able to clearly 
locate the CAF40 protein inside the complex. By two-hybrid analysis, it interacted 
with NOT1, suggesting it was closely associated with NOT1. CAF40 was also 
capable of interacting with hNOTl, but not with other hNOTs (data not shown), 
suggesting that NOT1 was a primary contact for CAF40. Since CAF40 interacted 
with the C-terminal 1300 residues o f hNOTl and also displayed weak interaction with
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C-terminal 630 residues of yeast NOT1 (data not shown), it is likely that CAF40 is 
associated with the C-terminal portion o fN O Tl. However, CAF40 also interacted 
with the N-terminal 1100 residues of NOT1 (see Figure 4B). The observation that 
CAF40 and CAF130 can display weak two-hybrid interactions with NOT4 supports 
the likely location o f CAF40 and part o f CAF130 to the C-terminal section o f NOT1 
where NOT4 is also located (Bai et al 1999).
CAF130 and CAF40 association with the CCR4 protein by 
immunoprecipitation was dependent on the CAF1 protein, an observation that supports 
our model that CAF1 is the only structural protein that links CCR4 with the rest o f  the 
complex. It also indicates that CAF130 and CAF40 are on the NOT1 protein side o f 
C A F1. A cafl 30 or caf40 deletion also did not affect the association o f other 
components with the complex, confirming that these two proteins were binding to a 
separate part o f NOT1 than the other proteins.
Phenotypic analysis o f cafl 30 and caf40 indicated that they had limited effects 
on many o f the typical processes affected by the other CCR4-NOT proteins: ADH2 
and HIS3 expression, caffeine sensitivity, temperature sensitivity and non- 
fermentative growth defects. The location o f CAF40 and CAF130 separate from 
CAF1-CCR4 and NOT2-5 supports these phenotypic differences. It is likely, based on 
the high evolutionary conservation of CAF40, that CAF40 will play important roles in 
the cell as found for the homologous RCD1 protein from S. pombe. The effect on 
sporulation by both rcdl and caf40 defects confirms this viewpoint. The distinct 
location for CAF40 and CAF130 implicates them in novel roles in the function o f the 
CCR4-NOT complex. Alternatively, as found for a not3 deletion (Liu et al 1998;
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Collart and Struhl 1994), point mutations in CAF4Q or CAF130 could result in more 
severe as yet undetected phenotypes than what was observed with deletion o f the 
whole gene.
The CCR4-NOT complex is an evolutionary conserved group of proteins. 
Mouse CAF1 (Draper et al 1995) and human NOT1, NOT2, NOT3, NOT4, CAF1 
(Albert et al 2000) and CAF40 (Okazaki et al 1998) have all been isolated. Through 
database analysis, we have also identified a CCR4 homolog in human and other higher 
eukaryotic organisms (unpublished observations). Only the human orthologs o f NOT5 
and CAF130 have yet to be identified. Whether the CCR4-NOT proteins form the 
same kind o f protein complex in other organisms as they do in the yeast, and whether 
the physiological roles o f these highly conserved proteins are retained in these 
organisms are two important questions that remain to be answered. Preliminary results 
with the deletion o f C. elegan CAF1 indicates that it results in multiple and distinct 
physiological effects (Gonczy et al 2000), confirming a key role for at least this 
component o f the complex. Based on the two-hybrid interactions observed for the 
mouse and human forms of the CCR4-NOT proteins (Draper et al 1995; Albert et al
2000), we predict that the structure o f the complex will be very much the same from 
yeast to humans and that the mammalian complex will also be involved in regulating 
various aspects o f mRNA synthesis and degradation.
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CAFl binds to a central region of NOT 1 (Bai et al 1999) and the NOT2, NOT5, and 
NOT4 proteins bind to a  C-terminal section o f NOT1 (Bai et al 1999; Maillet et al 2000). 
The location of NOT3 appears C-terminal although it is capable of making N-terminal 
contacts to NOT1 (Bai et al 1999). The association of CAF130 to both N- and C- 
terminal portions of NOT1 but to separate regions from that associated with other NOT 
proteins is described in the text. CAF40 also makes contact to both N- and C-terminal 
portions of NOT1 and binds to the NOT1 protein separately from other CCR4-NOT 
components.
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Chapter II
FUNCTIONAL ENZYMATIC ANALYSIS OF THE CCR4 PROTEIN 
Introduction
The CCR4 gene was initially identified by mutations that suppressed sptlO- 
enhanced ADH2 expression and affected the derepression of ADH2 and other non- 
fermentative genes (Denis 1984). However, it has become clear since then CCR4, 
CAF1, and other NOT proteins affect diverse processes in yeast and do so both 
positively and negatively (Liu et al 1998, 2001; Bai et al 1999; Badarinarayana et al
2000). CCR4 and its associated proteins have been implicated in multiple roles in the 
control o f mRNA metabolism, including initiation, elongation, and mRNA 
degradation. Some of the genes it affects are involved in non-fermentative growth, 
cell wall integrity, metal ion sensitivity and cell-cycle regulation. Part o f the 
repressive effects o f CCR4-NOT complex on gene regulation appear to occur through 
destabilizing functional TBP association with non-canonical TATAA sequences 
(Badarinarayana et al 2000; Lemaire and Collart et al 2000), and as components o f 
cytoplasmic deadenylase to enhance the rate o f degradation o f mRNA (Tucker et al
2001). It has been suggested that CCR4 is the deadenylase in this CCR4-NOT 
complex. Recently, the CCR4-NOT proteins also were found to function in 
transcriptional elongation. Defects in CCR4, CAF1, and NOT components elicit 6- 
azauracil (6AU) and mycophenolic acid sensitivities, which are hallmarks o f defects in
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elongation. ccr4 and cafl defects in combination with defects in factors known to be 
involved in elongation, such as TFIIS, SPT5, SPT16 and the RNA pol II subunits 
RPB1 and RPB2, result in allele-specific phenotypic defects (Denis et al 2001). 
Further, evidence has been introduced that shows that the CCR4 and CAF1 proteins 
physically associate with the known elongation factor SPT5 in vivo (Chiang et al
2001). CCR4 and CAF1 protein also reduce the formation of full-length lacZ mRNA 
by blocking expression of the 3’ end o f the gene (Y. Cui personal communication).
As mentioned in the general introduction, the CCR4 protein contains three 
major domains, and the C-terminal domain displays homology to a M g2+ dependent 
nuclease family. In this chapter of the dissertation, I present direct biochemical 
evidence that indicates that CCR4 is a 3’ ssDNA and RNase with a preference to poly 
(A) substrates. Mutations in the key catalytically important exonuclease residues 
abrogate CCR4 enzymatic activity and correspondingly CCR4 function in vivo. I 
demonstrate that the CCR4 protein is also capable of binding ssDNA and RNA. These 
findings strongly support the designation of the CCR4 protein as the catalytic unit of 
the cytoplasmic mRNA deadenylase. The enzymatic functions of the CCR4 protein 
suggest models of how the CCR4-NOT complex may also affect both transcription 
initiation and elongation.
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Material and Methods
Yeast strains, growth conditions, and enzvme assays
Yeast strains were grown at 30°C on YEP medium (2% yeast extract, 1% 
Bacto Peptone) or selective medium (Draper et al 1994) supplemented with either 4% 
glucose or 2% galactose/2% raffinose unless otherwise indicated. (3-gaIactosidase and 
alcohol dehydrogenase (ADH) assays were carried out as described previously (Bai et 
al 1999). Assay values represent the average o f at least three independent 
determinations.
DNA plasmid constructions
Site directed mutagenesis of the CCR4 proteins (ML400-1: E556A, ML400-2: 
D713A, ML400-3: D780A, ML400-4: H818A) was performed by sequencial PCR 
amplification methods using ML400 as the template (This work were done by Y.-C. 
Chaing). GST-CCR4 (C-terminal domain) and the its mutants were created by PCR 
amplification of the C-terminal domain (495-837) of CCR4 from ML400, and then 
cloned into pEG(KT), the yeast expression vector, with EcoRI and Sail. Full length 
CCR4 and its mutants, which have their own endogenous promoter sequences (ML400 
etc), were first constructed in pRS426 vectors. The CCR4-FLAG fusions were then 
generated by replacing BamHI-Sall pieces at the C-terminal end with PCR-amplified 
BamHI-FLAG-Sall fragments (Dunckley et al 1999). All the sequences of wild type 
and mutant plasmids were verified by sequencing of both strands.
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DNA and RNA substrate
The commercially synthesized ssDNA and RNA oligoes used in this study are 
listed below:
1. ADH2 (-178 to -139) 3’-CG: TAT AGC ATG CCT ATC ACA TAT AAA 
TAG AGT GCC AGT AGC G
2. CCR4 (2545 to 2572) 3’-5A: TAT GTG AAT TCT ATG CCA CCC CAA 
AAA
3. ADH2-C (-174 to -145): AAG TCG CTA CTG GCA CTC TAT TTA TAT 
GTG ATA GGC ATG C
4. ADH2-cb (-174 to -145): TAT AGC ATG CCT ATC TGT ATA TTT AAG 
AGT GCC AGT AGC G
5. RNA poly (A): UCU AAA UAA AAA AAA AAA AAA AAA AAA AAA
6. RNA poly (C): UCU AAA UAA AAA AAA AAA AAC CCC CCC CCC
By annealing ADH2 (-178 to -139) oligo with either the complete complemented 
ADH2 (-174 to -145) ssDNA or partially complemented ADH2 ssDNA which has 
only 10 unmatched nucleotides from -163 to -154 in the center, we were able to 
generate ADH2 dsDNA and ADH2 dsDNA with a  ssDNA bubble. The double stand 
DNA was created by first combining two 10 pmol ADH2 (-178 to -139) and ADH2-C 
(-174 to -145) ssDNA oligos, denaturing at 95°C for 5 min and annealing them by 
cooling to room temperature. The double stand DNA with ssDNA bubble was done 
the same way, but ADH2 (-178 to -139) and ADH2-cb (-174 to -145) were used 
instead. The annealed dsDNA were then purified by native TBE-PAGE gel. The 
dsDNA substrates (10 pmol) were labeled by Klenow DNA polymerase and [a 32 -P]
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dATP. The ssDNA substrates (10 pmol) were labeled either by T4 polynucleotide 
kinase and [y32 -P] ATP or terminal transferase and [a 32 -P] dATP as indicated in the 
text. The RNA oligo substrates (10 pmol) were labeled by T4 polynucleotide kinase 
and [y32- P] ATP. DIG-RNA substrates were generated using the T7-ADH2 (-180 to 
2) plasmid as the template, and utilized the protocols provided by Roche Biochemical. 
The capped mRNA (A60 and AO) substrates were generated exactly as described by 
Wilusz and co-workers (Ford et al 1997 and personal communication). AH the labeled 
substrates were subjected to gel filtration Sephadex G-25 spin columns to remove 
unlabeled nucleotides. The synthesized oligo substrates were extracted by phenol and 
precipitated by 2X ethanol and 10 ng/ml glycogen. The RNA polymerase synthesized 
DIG-RNA, as well as the A60 and AO substrates, were purified from 5% 
po!yacrylamide-7M urea gel prior to use. The radioactive substrates were then diluted 
and normalized to 10,000 cpm/pl. The amount of the DIG-RNAs was quantified by 
the DIG-Teststrips CRoche Biochemicals).
Protein extraction
The GST-CCR4 (C-terminal domain) proteins were purified from a protease- 
deficient yeast strain SC295. Cells were grown overnight to stationary phase in 
selective medium with 4% glucose. The 50 ml overnight culture was spun down, and 
washed to remove glucose. The cells were then transferred to 500 ml fresh medium 
containing 2% Galactose/ 2% Raffinose for an additional incubation to late log phase 
(OD6oo=1.5) to induce expression of the GST fusion protein. The cells were collected, 
and resuspended in HEPES buffer (50 mM HEPES-NaOH, pH 7.6, 150 mM NaCl, 1
53
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
mM EDTA, 20% glycerol, 0.01% NP40) plus a protease inhibitor cocktail. The cells 
were lysed with at least 80% lysis efficiency by a bead beater using 15 cycles o f 
vortexing for 1 min periods followed by incubating 2 min on ice. The lysate was 
cleared by centrifugation at 14,000 g for 10 min, and then ultracentrifiiged at 100,000g 
for 45 min at 4°C. The clear supernatants were incubated with pre-equilibrated 1.5 ml 
GST beads for 4 hrs. The GST beads were then extensively washed five times using 
15 ml HEPES buffer with protease inhibitors. The bound GST fusion proteins were 
eluted twice in 1.5 ml each HEPES buffer containing 50 mM glutathione. Two 
elutions were pooled, dialyzed against the 4 L HEPES buffer for 24 hr with two 
changes of buffer, and concentrated using the Centricon 30. The GST fusion protein 
extracts were analyzed by standard 8% SDS-PAGE, and visualized by Coomassie blue 
staining. The concentrations o f the fusion proteins were measured by comparing the 
density o f standard 1 mg/ml BSA to that o f the extracts.
CCR4-FLAG fusion protein purification was essentially conducted as 
described previously with a few modifications (Dunckley et al 1999). A 500 ml 
KY803-la-l yeast culture containing CCR4-FLAG fusion was grown to late log phase 
in selective medium with 4% glucose. The cells were washed and lyzed in HEPES 
buffer as described above. After clarification of the crude cell lysate following the 
same procedures as described in the GST purification, the supernatants were incubated 
with 500 |il anti-FLAG M2 affinity agarose (Sigma) at 4°C overnight. After extensive 
washes, the bound FLAG fusion proteins were eluted twice by HEPES buffer 
containing 200 pg/ml Flag peptide (Sigma). The eluates were dialyzed as described 
above, and concentrated using a Centricon 10. The CCR4-FLAG fusion protein
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extracts were subsequently run on a 4-15% gradient SDA-PAGE gel. The protein 
bands on the gels were analyzed either by silver staining or by standard western 
analysis. The concentrations o f the preparations were quantified by Bradford assay.
Gel-mobilitv shift DNA binding assay
The EMSA reactions were performed in a HEPES binding buffer (50 mM 
HEPES-NaOH, pH 7.6, 150 mM NaCl, 2 mM MgCl2, 10% glycerol, I mM DTT, 1 \ig 
poly (dA-dT)). Two |il o f the ssDNA or dsDNA radioactive substrates (-10,000 
cpm/fil) were incubated with GST-CCR4 or its mutants (-2  (ig to 12 (j.g) at 30°C for 1 
hr. For the antibody supershift assays, the reaction mixtures were first incubated for 
30 min, and then antibody (~ 100 ng to 200 ng) was added to the reaction for another 1 
hr incubation. The total reaction mixtures (20 p.1) were separated on a pre-run 4°C 6% 
0.5X TBE polyacrylamide gel. After a 15V/cM electric field was applied to the gel 
for 15 min to ensure rapid entering o f  the samples into the matrix, electrophoresis was 
continued at 8 V/cm for several hours. Gels were then dried prior to autoradiography 
or for Phosphor imager (Bio-Rad) analysis.
UV crosslinking assay for RNA-protein interaction.
The nonradioactive UV cross-linking assay was described in detail by Vaquero 
and co-workers (Vaquero et al 1998). Briefly, 100 ng GST-CCR4 protein were 
incubated with 100 finol DIG-labeled RNA in a volume of 30 fil o f HEPES buffer (50 
mM HEPES-NaOH, pH 7.6, 150 mM NaCl, 2 mM MgCl2, 1 mM EDTA, 10% 
glycerol, 1 mM DTT) plus protease inhibitors cocktail for 1 hr at 4°C using siliconized
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tubes. The reaction mixtures were transferee! to a 96 well microtitration plate for UV 
irradiation (800 mJ) in a Gene linker UV chamber (Bio-Rad). The samples were then 
treated with 0.5 pg RNAse A for 15 min at 37°C to remove unbound RNA, boiled for 
5 min in SDS loading dye buffer, and loaded onto a 8% SDS-PAGE gel. Samples 
were prepared in triplicate, one for Coomassie or silver staining, one for DIG- 
chemiluminescence detection and one for standard western detection. The 
protein/DIG-RNA gel was electro-blotted onto nylon membranes (Millipore), which 
were subjected to DIG-chemiluminescence detection exactly as described in the 
protocols provided by Roche Biochem icals. Both western and DIG- 
chemiluminescence membranes were exposed to Kodak X-ray film for detection.
In vitro enzymatic Assay
The standard enzymatic assays (10 |il) contained HEPES binding buffer (50 
mM HEPES-NaOH, pH 7.6, 150 mM NaCl, 2 mM MgCl2, 10% glycerol, 1 mM DTT 
plus RNase inhibitors (Ambion)), 1 pi of radioactive substrate (10,000 cpm) and IX 
protein (160ng). Routinely, for concentration assays, 1 pi o f radioactive labeled DNA 
or RNA substrates (10,000 cpm) was incubated with a standard 1 fold GST- 
CCR4/CCR4-FLAG protein (lX=160ng) or other fold changes o f protein as indicated 
in the Figures for 45 min at room temperature, and was stopped by addition o f an 
equal volume formamide/EDTA gel loading buffer. For the time course assay, the 
whole cocktail for all the time points (5 to 6 o f reaction mixtures) were made. After 
incubation at room temperature at each time point showed in the Figures, 10 pi o f 
reaction mixtures were taken out, and the reaction was stopped by addition o f an equal
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volume o f the formamide/EDTA gel loading buffer. After boiling for 5 min, the 
reaction mixtures were loaded onto a 7 M urea, 14% sequencing polyacrylamide 
denaturing gel. The products were analyzed and quantified by a Phosphor imager and 
its attached software (Bio-Rad).
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Results
The CCR4 protein is a member of the M g2+ dependent Exo III /HAP1 (APE1) 
nuclease family
The CCR4 protein consists o f three apparent functional regions (Draper et al 
1994). The N-terminal part of the protein contains a glucose regulated transcriptional 
activation domain. A central leucine rich repeat (LRR) domain is required for its 
binding to CAF1 and other CCR4-NOT associated factors (Draper et al 1994, 1995; 
Liu et al 1997,1998, 2001). The C-terminal region has been shown to share 
homology with a number o f  eukaryotic proteins (Green et al 1996), deletion o f which 
in CCR4 inactivates the protein (Draper et al 1994). In order to identify a possible 
functional domain for the C-terminal region o f CCR4, we performed PSI-BLAST 
searches of the non-redundant protein database using the amino acid sequences o f the 
CCR4 C-terminal domain (495-837) as a probe. The C-terminal domain o f the CCR4 
protein shared high homology with exonuclease III (E.coli) and HAP1 (APE1) (H. 
sapiens), an apurinic (AP) endonuclease (Figure 1 A). Further, by performing Clustal 
W 1.8 and PIMA multiple sequence alignment, together with Block Maker search, we 
were able to align the CCR4 C-terminal domain within this Mg 2+-dependent ExoIII 
/HAP1 (APE1) nuclease family. As previously reported by Dlakic (2000) and 
Whisstock et al (2000), this family o f proteins also include APN2 (yeast AP 
endonuclease), noctumin, sphingomyelinases, iniositol phosphatases and other 
nucleases or phosphatases. In S. cerevisiae, there exists a group of CCR4 C-terminal 
like proteins, namely APN2, YOL042w (NGL1), YMR285w (NGL2) and YML118w 
(NGL3).
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All o f above proteins share five highly conserved motifs as follows: I: SYNTL, 
II: C L£E, III: GDFN, IV: IDYI and V: PSDH_(Figure IA). Based on the high 
resolution X-ray crystal structure o f ExoIII (Mol et al 1995) and the human APE1 in 
complex with abasic DNA (Gorman et al 1997; Mol et al 2000), all five motifs play 
critical roles for AP endonuclease as well as phosphatase activities. For APE1, the 
aspartate and hisidine residues in the respective motifs IV and V make a direct 
hydrogen bond with the target AP site 5'-phosphate. Phosphodiester bond cleavage is 
achieved by hydroxyl nucleophile attack by the aspartate residue in motif III. This 
aspartate residue is correctly oriented by hydrogen bonds from the asparagine residue 
in the motif I. The metal ion binding motif II utilizes a glutamic acid residue to bind 
M g 2+ ion, stabilize the transition state, and facilitate the OH' leaving group.
Using the Clustal methods in Megalign program from DNA star software 
(DNA star), we generated a phylogenetic tree relating the C-terminal CCR4 region 
with other proteins containing these five motifs (Figure IB). As expected, CCR4 
(yeast) and human CCR4 were extremely closely related. The CCR4-like proteins in 
yeast (NGL1, NGL2, NGL3) and noctumin share a high degree of sequence 
homology, whereas the nucleases Exo HI, APN2 and human HAP1 (APE1) are more 
distantly related. The CCR4 and CCR4-like proteins clearly share homology to 
Exom / hHAPl (APE1). The same is true of sphingomyelinase and inisotol 
phosphatases, such as ISC1 (yeast sphingomyelinase) and INP54 (one of the yeast 
inisotol phosphatases). However, these lipid related enzymes are further distant from 
the CCR4 protein group than are the nucleases. This analysis suggests that CCR4 is 
most likely to contain nuclease activities.
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Exonuclease III represents about ~90% o f the total AP endonuclease activities 
in E.coli. In addition to its AP endonuclease activities, ExoIII also displays related 
DNA/RNA enzymatic activities, include 3'-phosphodiesterase and 3'- 
phosphomonoesterase activities, RNase H activity, and 3'-5' exonuclease activity. 
Similarly, HAP1 (APE1) protein, the major AP endonuclease in human cells, also 
displays the same variety of enzymatic activities related to DNA/RNA metabolism 
(Barzilay et al 1995; Gorman et al 1997; Nguyen et al 2000). We subsequently 
investigated the enzymatic functions of the CCR4 protein as suggested from this 
bioinformatic analysis.
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Figure 1A Sequence alignment of CCR4 protein within Mg2+ dependent
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A. By performing Clustal W 1.8 and PIMA multiple sequence alignment 
together with Block Maker search, we aligned the C-terminal domain o f CCR4 
protein, its yeast homologs (YOL042w, YMR285w and YML118w) and human 
ortholog (KIAA1194) with the ExoIII, HAP1 (APE1), APN2 (yeast ortholog o f AP 
endonuclease), ISC1 (yeast sphingomyelinase), and INP52 (one o f the representative 
yeast inositol 5’-phosphatase). The most conserved catalytic amino acid residues are 
highlighted as black background. The critical catalytic amino acids for enzymatic 
reactions are also marked with an asterisk at the top o f each motif. The residues with 
at least four amino acids conserved in the same position are highlighted as gray 
background. (The amino acids leucine and isoleucine were considered to be identical 
for this analysis).
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B. Phylogenetic tree for the C-terminal domain of CCR4 protein and 
enzymatic domains from this nuclease family aligned by Clustal methods from DNA 
star. The branch length represents approximate divergence from an ancestral node. 
The amino acids o f each domain used in this analysis are indicated next to the protein 
name. Otherwise, the protein represent the full length protein.
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Mutation of the conserved amino acids in CCR4 impairs the function of CCR4 
(The data in this section were kindly provided by Yueh-Chin Chiang)
We mutated the four o f the most conserved residues E556A, D713A, D780A, 
H818A in the CCR4 protein as suggested by above analysis that correspond to motifs 
II through V. These point mutations will be designated as ccr4-l (E556A), ccr4-2 
(D713A), ccr4-3 (D780A) and ccr4-4 (H818A) respectively.
The mutated genes were then respectively integrated at the TRP1 locus in a 
strain containing a ccr4 deletion. All four proteins were expressed at the levels 
comparable to the wild-type CCR4 (data not shown). Mutation of the key M g 2+ 
binding residue (E556A) which blocks endonuclease activity in other members o f this 
family completely abrogated CCR4 function in vivo (Table 1). In two strains tested, 
ccr4-l displayed defects in cold sensitivity (13° C), glycerol utilization (37° C 
glycerol), cell wall integrity (8 mM caffeine), and elongation (6 AU). The defects 
were so severe that the mutants showed the same phenotypes as the ccr4 deletion 
allele. Mutation of the histidine residue (H818A), which is involved in nucleophilic 
attack during catalysis, also significantly reduced CCR4 function. In the EGY188 
strain background, the ccr4-4 allele showed weak growth on non-fermentative carbon 
source, and media containing with caffeine or 6 AU. However in the MD9-7C strain 
displayed more severe phenotypes (Table 1). The mutation o f the other conserved 
catalytically important residues (D780A, D713A) did not affect CCR4 functions in the 
EGY188 strain, however they displayed glycerol growth and caffeine sensitivity 
defects on the MD9-7c strain background. Uniquely, only the ccr4-2 allele (D713A) 
in MD9-7C strain did not grow in the 13° C condition, while the other mutants showed
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weak growth. These results indicated that the residues of the CCR4 C-terminal 
domain that are functionally homologous to those present in the Exo III nuclease 
family are critically important to CCR4 function in vivo. We have also noted that this 
C-terminal region defines a unique and independent domain o f CCR4 in that this 
region when overexpressed by itself could partially suppress a ccr4 non-fermentative 
growth defect (data not shown).
Each o f the proteins was also analyzed for its ability to interact with CAF1 
protein both by two hybrids assays and immunoprecipitation. No differences in 
binding were observed (data not shown), consistent with the observation that leucine 
rich repeats o f CCR4 is important for the interaction with CAFl protein (Liu et al 
1998; Draper et al 1995), suggesting that the C-terminal domain o f CCR4 is not 
responsible for this function.
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Table 1 Mutants in the conserved catalytic residues severely affect physiological
functions of CCR4 in vivo

















CCR4 + + + + + + + + +
ccr4-l fE 5 5 6 A ) - - w - ++ - - W
ccr4-2 fD 713A '» + + + + + + - - -
ccr4-3 CD780A') + + + + + + - - w
ccr4-4 fH 8 0 8 A l w W w + + + - - w
ccr4 - - - - - - - -
Table 1. All strains are isogenic either isogenic to EGY188 or MD9-7C as indicated 
on top of the columns. Growth was scored as : ++ very good; + good; w weak; - 
none.
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The CCR4 protein binds to ssDNA
In order to investigate whether the CCR4 protein displays any DNA/RNA 
nuclease activities, we first tested the capability of the CCR4 protein to bind to DNA 
or RNA. We used GST-CCR4 (495-837) fusion protein to investigate this. The 
recombinant GST-CCR4 protein was purified to -80%  purity from a pro tease- 
deficient yeast strain SC295 (Figure 2A). The 40 mer single strand oligonucleotide, 
ADH2 3’-CG, was labeled at its 3’-end by terminal transferase and [a-32 P] dATP.
We performed an electrophoresis mobility shift assay (EMSA) to reveal GST-CCR4 
and ssDNA interaction (Figure 3A). As shown in Figure 3A lane 2 through 4, GST- 
CCR4 protein resulted in the formation o f a specific gel shift band, the density o f the 
bands increased as the concentration of GST-CCR4 was increased. In contrast, the 
control GST alone did not result in any comparable gel shift band (lane 8 and 9). 
Incubation with excess unlabeled ssDNA also prevented the formation o f  the putative 
GST-CCR4-ssDNA complex (lane 10). The gel shift bands marked with asterisks in 
Figure 3 A result from contaminant proteins, and were not constantly observed in other 
GST-CCR4 preparations. The fact that the E556A mutation in GST-ccr4-l did not 
affect ssDNA binding is expected, since the mutation o f the catalytic residues o f  APE 1 
or Exo III did not interfere with DNA association (Barzilay et al 1995; Mol et al 
2000). Interestingly, GST-ccr4-l repeatedly displayed stronger interaction with the 
ssDNA than did wild-type GST-CCR4 (see Discussion). GST-CCR4 could also 
interact with a  different ssDNA oligo derived from the HIS4 gene (data not shown), 
which suggests that GST-CCR4 binds to ssDNA regardless o f its DNA composition. 
Since ATP may enhance protein-DNA interactions (Garber et al 2000), we also
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investigated whether ATP had any effect on the interaction. However, we noted that 
adding 1 mM ATP to a reaction mixture did not enhance any GST-CCR4 binding to 
the ssDNA (data not shown).
In order to confirm our gel mobility shift results, we incubated anti-GST 
antibodies together with GST-CCR4 and the labeled ssDNA. The anti-GST antibody 
resulted in the formation of a super-shifted complex (Figure 3B lane 6, 7, 8, 9). Also 
the standard shift bands and the super-shift bands corresponded in abundance to the 
GST-CCR4 protein concentration that was added (compare lane 3 to lane 6, 8; lane 4 
to lane 7, 9 for standard shift bands intensity; compare lane 6, 7 to lane 8, 9 with anti- 
GST antibody concentration increase for super-shift bands intensity). We were not 
able to detect any super-shift bands when we incubated purified anti-CAFl antibody 
with the mixture o f GST-CCR4 and ssDNA complex (lanes 12 through 15), nor were 
we able to detect super-shift bands when we mixed purified anti-GST antibody 
together with GST protein in combination with ssDNA (lanes 16and 17). We 
conclude, therefore, that the specific super-shift bands were caused by anti-GST 
antibody interaction with GST-CCR4 protein complexed to the ssDNA and forming a 
super shifted DNA-protein complex.
Taken together, our results indicated that the CCR4 protein binds specifically 
to single strand DNA.
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The molecular weight standards are indicated in the Figure. The concentration 
of each GST fusion protein was determined by comparing the density o f the band with 
that o f the standard BSA protein.
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Figure 3. GST-CCR4 binds to ssDNA in vitro.
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The 40-mer ssDNA was labeled with terminal transferase, and the 
electrophoresis mobility shift assay (EMS A) was performed according to the Material 
and Methods. The concentration of GST-CCR4 and GST-ccr4-l protein were 4 fig, 8 
fig, and 12 fig, while the concentration o f GST control protein was increased from 8 
fig to 12 |ig. The 8 fig o f  GST-CCR4 protein incubated with 10 fold excess ssDNA 
(100 pmol) was loaded on lane 10 as negative control.
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Figure 3B.
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The GST fusion protein concentrations used in this assay were indicated in the 
Figure with 2X equal to 2 jig, the concentration o f antibody IX equals to 100 ng. The 
position of the super-shifted protein complex is indicated in the Figure. Both in A and 
B, the bands marked with asterisks are regarded as non-specific protein-DNA 
interaction bands, since these bands showed different intensities in different protein 
preparations. However, the super-shifted protein complexes were observed regardless 
o f different preparation.
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CCR4 protein does not bind to dsDNA
We also explored the possibility that GST-CCR4 was capable to binding 
double strand DNA (dsDNA) or dsDNA containing unmatched ssDNA region in the 
center. The dsDNA were labeled at 5’-end by DNA polymerase Klenow fragment and 
[a-32P] dATP. Following the same EMSA procedures performed by the GST-CCR4- 
ssDNA binding, we were not able to detect any mobility difference in the labeled 
dsDNA (data not shown). These results agreed with previous results suggesting that 
the CCR4 protein could not bind to dsDNA (Draper et al 1994).
CCR4 protein binds to RNA
We further investigated whether GST-CCR4 protein binds to RNA. At first, 
we failed to detect any labeled RNA oligo in our RNA gel mobility shift assays. This 
probably occurred because as we later discovered that the CCR4 protein actually 
encodes deadenylase (Tucker et al 2001; this dissertation) and 5’-phosphatase (this 
dissertation) activities that remove 5’- or 3’-end radioactive labels. We subsequently 
took another approach using UV cross-linking assay to study CCR4-RNA interactions 
(Molnar et al 1995; Vaquero et al 1998). An ADH2 RNA (-180 to 2) was internally 
labeled by T7 RNA polymerase and digoxigenin (DIG)-UTP. The advantage o f this 
DIG-RNA labeled probe was that it was internally labeled by DIG-UTP, an analogue 
of UTP, which may not be recognized by RNase or phosphatase. By fixing the 
interaction between GST-CCR4 and RNA using UV irradiation, we could measure the 
interaction on a denaturing SDS-PAGE gel by using Western and DIG- 
chemiluminescence detection. By comparing the migration o f CCR4 by Western
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analysis with that DIG-RNA detection (Figure 4A and 4B), we were able to locate the 
GST-CCR4 and novel RNA interaction bands (see lanes 1 and 2; 9 and 10). The 
degree o f interaction corresponded with the increase in GST-CCR4 protein 
concentration. GST-ccr4-l and GST-ccr4-Del (A603-667) also showed interaction 
with the RNA probes (lanes 3, 4, 5, and 6), in agreement with the ssDNA binding 
activity o f GST-ccr4-l and GST-ccr4-Del. The control GST protein alone did not 
show any ability to bind RNA (Figure 4A lanes 7 and 8). All these data suggested that 
GST-CCR4 protein is capable o f binding to RNA.
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Figure 4. GST-CCR4 binds to RNA.
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GST-CCR4 protein interaction with RNA was investigated using UV-cross- 
linking methods described in the material and methods. GST-ccr4-del is a truncation 
of the C-terminal of CCR4, which lacks amino acids from 603 to 667. In the Figure, 
the protein concentration IX stands for 4 |ig of GST fusion protein. The RNA and 
protein interaction bands are indicated in the figure. The GST-CCR4 protein bands 
were also visualized by Coomassie and silver staining.
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C-terminal CCR4 protein displays 3’-5 exonuclease and 5’-phophatase activity
Since the highly conserved C-terminal domain o f CCR4 shared homology to 
the Exo III/ HAP1 (APE1) exonuclease, we first tested whether C-terminal domain of 
CCR4 showed any enzymatic activities. Using the same purified GST-CCR4 (C- 
terminal) fusion protein, we assayed the enzymatic activities for the ssDNA, dsDNA, 
dsDNA with ssDNA bubble, and RNA substrates.
The dsDNA and dsDNA with ssDNA bubble were labeled at the third 
nucleotide at the 5’-end using DNA polymerase Kleown fragment and [y-32 P] dATP. 
After incubation GST-CCR4, or GST-ccr4-l with the two above dsDNA substrates, 
we could not detect any truncated dsDNA species (data not shown). Also GST-CCR4 
did not result in any decreased intensity of the radioactive probes compared with GST 
alone (data not shown). These results suggest that the C-terminal domain o f  CCR4 
protein may not have any endonuclease activities.
We subsequently studied the enzymatic activities o f the C-terminal domain of 
CCR4 protein on ssDNA and RNA substrates. Two ssDNA were used in this study: 
one was a 40-mer oligonucleotide with CG at the 3’-end, the other was a 27-mer 
oligonucleotide with AAAAA at the 3’-end. One RNA substrate was also employed, 
which was a 30-mer RNA oligonucleotide with twenty adenines (20A) at the 3’-end. 
All these substrates were labeled at their 5’-end by T4 polynucleotide kinase (PNK) 
and [y-32 P] ATP. As shown in Figure 5, the GST-CCR4 protein clearly removed the 
radioactive [y-32 P] both on the ssDNA and RNA substrates (Figure 5 lanes 2 lane3), 
while the GST-ccr4 (-1, -4) mutant and GST protein controls did not remove a 
comparable amount o f label (lanes 4, 5 and 6, 7). These data demonstrate that the
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CCR4 C-terminal domain displays 5’ phosphatase activity on both ssDNA and RNA 
substrates.
Interestingly, we also observed that at the same concentration of GST-CCR4 
(lane 2), CCR4 protein displayed a greater activity with the RNA substrate as 
compared to the ssDNA substrate. Relatedly, GST-CCR4 displayed more activity 
with the ssDNA substrate containing 5As at the 3’-end than with the ssDNA with the 
3' CG end, although the length o f these substrates could also have contributed to the 
differences in activity. These results suggest that the 5’ phosphatase activity o f GST- 
CCR4 preferred RNA, and poly (A) ssDNA over non-poly (A) ssDNA as its 
enzymatic substrates. This also agreed with our finding that CCR4 was a major 
component o f  the mRNA deadenylase (Tucker et al 2001) and a 3’-5’ poly (A) 
exonuclease (This dissertation).
To further investigate the 3’-5’ poly (A) exonuclease activity o f this GST- 
CCR4 protein, we labeled the 40-mer ssDNA oligo (CG 3'-end) at the 3’-end with 
terminal transferase and [a -32 P] dATP. From the protocols provided by Roche 
Biochemicals the terminal transferase incorporated about 75-125 nucleotides into the 
dsDNA structure at the standard condition. However we did not observe that long tail 
at the 3' end of our ssDNA. Instead, we usually had two to three radioactive [a -32 P] 
dATP incorporated. As shown in the Figure 5B, the time course o f the reactions, we 
can clearly identify a loss o f one nucleotide following incubation with GST-CCR4 
with 30 min to 4 hrs as shown in lanes 1 through 6. The GST-ccr4-l mutant and GST 
proteins again did not cause any shift (Figure 5B). The single nucleotide shift was 
possibly resulted from GST-CCR4 3’-5’ exonuclease activity in that it removed one
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nucleotide from 3’-end or it could be loss one nucleotide from the 5’ end. Also it 
demonstrated that CCR4 C-terminal domain alone was not a processing exonuclease 
that was able to remove additional labeled the nucleotides.
We therefore demonstrated that C-terminal domain o f CCR4 protein displayed 
exonuclease and 5’-phosphatase activity and substrate specificity for both ssDNA and 
RNA. However the other enzymatic properties o f  this CCR4 protein may lie in the 
full length CCR4 or the CCR4 associated complex. This will be addressed later in the 
next section o f dissertation.
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A. The 5’-phosphatase activity of GST-CCR4 (C-terminal domain) was investigated 
in three different 5’-labeled substrates: ssDNA with 3’- CG; ssDNA with 3’-5A; and 
RNA with 3’-20A. The different substrates are indicated in the left panel. The 
enzymatic reaction time was 30 min. The protein concentration IX stands for 160 ng 
of the GST fusion of protein.
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B. Time course of enzymatic activity of GST-CCR4 fusion protein.
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The 3’-CG 40-mer ssDNA substrate was labeled by terminal transferase, and 
incubated with 360 ng of GST-fusion protein (60 ng protein per reaction). At the 
indicated time point, a 10 |il of reaction mixture were removed any assayed for the 
ssDNA products. The positions of the two intact ssDNA inputs were indicated on the 
right of each panel. However, in the GST-CCR4 panel, an extra ssDNA product band 
occurred as marked at three positions on this specific panel.
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The CCR4 protein is a 3’-5’ poly (dA) ssDNA exonuclease
In order to further characterize the enzymatic function o f the CCR4 protein, we 
constructed a full length CCR4 protein with a FLAG tag at its C-terminal end. Upon 
transformation into a ccr4A strain. We purified a functional CCR4-FLAG fusion 
protein, as well as its associated factors following a one-step affinity chromatography. 
Based on the silver staining (Figure 2C) and Western analysis (Figure 2B), our 
purified material contained CCR4-FLAG, CAF1, CAF40, and NOT 1-5 proteins 
(Figure 2B), suggesting that the integrity o f the CCR4 complex was intact. This 
purified CCR4-FLAG preparation was than assayed for its enzymatic activities on 
ssDNA substrates. Two previously described ssDNA substrates were studied in this 
CCR4-FLAG enzymatic assay. For the ssDNA substrate with the 3’-CG end, we did 
not observe any degradation o f the input ssDNA (Figure 6A). With different 
concentrations o f  the CCR4-FLAG material, we observed a small amount o f 5’- 
phosphatase activities that removed the labeled [y-32 P] ATP over longer incubation 
time (over 30 minutes). We believe that this is a contaminant phosphatase that 
coexisted in our extracts since ccr4-l-FLAG displayed the same activity.
In contrast, for the ssDNA substrate with the 3’-5A end, we found that CCR4- 
FLAG was able to shorten the input ssDNA to produce a product that was 4 
nucleotides shorter (Figure 6B lanes 2 to 5). With a lower concentration o f the wild- 
type CCR4-FLAG protein (32 ng), we observed all o f the four intermediate products 
of this enzymatic process. Since this substrate was 5’-end labeled, these products 
represent shorter ssDNA species following trimming from the 3’end. Moreover, we 
observed the accumulation o f substrates lacking four nucleotides, which suggested that
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the CCR4-FLAG wild type protein was not able to process further into the ssDNA 
without at least two 3' A being present. The ccr4-l mutant protein, containing the 
E556A alteration which would abrogate CCR4 capability to bind the Mg2+ ion, was no 
longer capable o f degrading this ssDNA substrate (lanes 6 to 13). Also this enzymatic 
function was totally dependent on CCR4-FLAG protein. In the extracts from ccr4A 
without CCR4-FLAG plasmid, we did not observe any enzymatic function (lanes 14 to 
16).
We subsequently analyzed the 3’-5’ dA exonuclease activity o f CCR4-FLAG 
protein as a function o f time. As shown in the Figure 6C, with a five minute 
incubation, we saw predominately the input and the ssDNA with one nucleotide 
removed, with lesser amounts o f other shorter species. At the ten-minute reaction 
time, there were almost equal amounts o f five species in the reaction mixture. When 
the incubation time was increased to 1 hr, we observed only the ssDNA substrate with 
four nucleotides removed. We quantified the density o f each band using phosphor 
imager analysis, and plotted them as shown in Figure 8A as function o f time. As the 
incubation time increased, the input ssDNA substrate became diminished, while the 
second, third and fourth intermediate bands consequently showed an increase in 
formation followed by a decreased in abundance. The fifth band reached its peak 
amount at about 30 min and decreased slightly at 1 hr, possibly a result o f a 
contaminant 5’ phosphatase in the preparation. By calculating the input ssDNA 
density change (first band), we could identify a typical enzymatic reaction curve as 
percentage o f reaction vs time (Figure 8B, curve 1). The half-life T \a was estimated to
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be 8.5 minutes at 160 ng wild-type CCR4-FLAG protein. Repeated experiments 
showed almost the same half-life T \a of ssDNA substrates.
We did not observe any enzymatic activity on dsDNA substrates using CCR4- 
FLAG protein (Figure 7A). Together, based on all the above results, we conclude that 
CCR4 protein is a 3’-5’ poly (dA) ssDNA exonuclease.
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The proteins specifically binding to the FLAG beads were analyzed by 
standard Western Blot using the antibodies as indicated.
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CCR4-FLAG fusion proteins were analyzed by 4%-15% gradient SDS-PAGE 
gel prior to silver staining.
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Figure 6. The CCR4 protein is a 3’-5’ poly (dA) ssDNA exonuclease.
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Figure 6B
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A and B. CCR4-FLAG fusion proteins were incubated with two different 5 ’- 
labeled ssDNA substrate: 40-mer oligo with 3’-CG and 30-mer oligo with 3’-5A. 
Four protein extracts were used in this assay, CCR4-FLAG fusion protein, two ccr4 
mutated FLAG fusion proteins, and extracts from a strain containing ccr4A without 
bearing any FLAG fusion protein. The concentration of each protein used in this 
assay is indicated with 1 representing 160 ng.
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C. The time course of the CCR4-FLAG enzymatic activity on 5’-labeled ssDNA
with 3’-5A.
Figure 6C 
Blank CCR4-FLAG ccr4-1 -FLAG ccr4-(-1,-4)-FLAG ccr4
0 5 102030 60 0 510 20 30 60 0 5 10 20 30 60 0 5 10 20 30 60 0 5 10203060
The standard time course reaction was carried out according to the Material 
and Methods. The number above the lane indicated the time point at when the 
reaction was stopped. Four protein extracts were employed in this assay as indicated. 
The gel was crushed at the position o f the ccr4 mutant reaction mix. However the 
trend is still obvious.
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— * - ------------ ----------------- 1
SSD NA-CCR4 (160 ng)
R N A -C C R 4 (80 ng)
R N A -C C R 4 (160 ng)
0 10 20 30 40  50 60
T im e  (min)
A. After measuring the density o f each ssDNA band present in the wild-type 
CCR4 fusion protein panel in the Figure 6C using a phosphor imager, we plotted the 
density o f the the DNA band as a function of time. Each curve represents one ssDNA 
species as indicated by different colors in the Figure.
(continue)
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B. The percentage o f ssDNA or RNA substrate remaining as a function o f 
time. The intensity o f  the input ssDNA with 3’-5A (top band in the Figure 6C), and 
the input RNA with 3 ’-20A (top band in Figures 9A and 9B) from wild type CCR4- 
FLAG fusion protein were plotted in this Figure. The protein concentration in these 
assays were indicated.
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The CCR4 protein is a RNA poly (A) exoribonuclease
Tucker and co-workers have purified a FLAG-CAF1 fusion protein along with 
its associated factor CCR4 and several additional proteins, and found it contained a 
mRNA deadenylase activity (Tucker et al 2001). Conterminously, we directly assayed 
for CCR4 poly (A) deadenlyase activity by using purified CCR4-FLAG protein and a 
30-mer RNA oligonucleotide with a 3’-poly (A) end. After incubation o f  poly (A) 
RNA substrates with 80 ng o f CCR4-FLAG for 5 min, we identified a ladder pattern 
o f deadenylated RNA species on the denaturing gel (Figure 9 lanes 6 to 10). With 
increased incubation time, CCR4-FLAG resulted in increase abundance o f the shorter 
species. However we did not observe the same phenomena in the RNA substrate with 
3’ poly (C) end (Figure 7B). Similarly as with the ssDNA substrates, we plotted the 
density change o f the first input RNA substrate band versus time to demonstrate the 
properties o f the CCR4 protein. As shown in the Figure 8 curve 2, at the 80 ng CCR4-
FLAG extracts, the half-life o f RNA substrate T 1/2 was identified at about 2.5 min.
To further investigate substrate specificity, we used the same amount o f the CCR4- 
FLAG extracts (160 ng) as used in the ssDNA degradation to incubate with RNA 
substrate. The reaction was extremely quick: at the 10 min point, most o f the substrate 
degraded to completely processed RNA products (Figure 9B). We plotted the data
into Figure 8 curve 3, and the RNA substrate T 1/2 was also about 2.5 min. Clearly at
the same concentration, the T 1/2 o f RNA substrate was much shorter than that o f
ssDNA substrate. This suggested that the RNA was the preferred substrate for CCR4 
protein as compared to the ssDNA substrate. These results also agreed with the results
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obtained with the GST-CCR4 fusion protein which could remove the 5’ phosphate 
from RNA much faster than the ssDNA.
Since the ccr4-l mutation (E556A) had the most severe impact on yeast 
function in vivo, we also investigated the RNA poly (A) deadenlyase function o f this 
mutant protein. In contrast to the proficient degradation of the RNA substrate by the 
wild type CCR4 protein, the ccr4-l mutant protein did not display any RNA 
deadenlyase activity (Figure 9A, lanes 11 to 15 and Figure 9B, lane 13 to 18). 
Although we still observed that the RNA band lost radioactive intensity over the 
longer incubation time (1 hr), we believed it was the same contaminant phosphatase in 
the extracts as was observed with wild type CCR4-FLAG. These observations 
together with the ccr4-l protein effect on ssDNA degradation demonstrated that the 
severe in vivo phenotypes o f ccr4-l mutant were most likely to result from defect in 
its DNA/RNA enzymatic function.
We also investigated the effect o f CCR4-FLAG on capped mRNA substrate 
with 3’-60A poly (A) end, which was synthesized from Sp6 RNA polymerase by 
incorporating radioactive [a-32P] UTP into the length o f the RNA. CCR4-FLAG 
extracts could degrade this capped mRNA, while the ccr4-l mutant and ccr4A extracts 
could not degrade this substrate (Figure 10). In contrast to the capped mRNA poly 
(A) substrate, wild-type CCR4-FLAG extracts could not degrade a capped mRNA that 
lacked 3' As (AO).
Based on above results, in addition to its 3’-5’ poly (dA) ssDNA exonuclease, 
CCR4 is also a RNA deadenlyase.
90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 7. The substrate specificity of CCR4-FLAG fusion protein.
Figure 7A
ccr4 CCR4-FLAG ccr4-1-FLAG ccr4-(-1 ,-4)-FLAG
c  1/10 1/5 1 1/201/10 1/5 1 1 /201 /101 /5  1 1/20 1/10 1/5 1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 1 6
7B
ccr4 CCR4-FLAG ccr4-1-FLAG ccr4-(-1 ,-4)-FLAG
c  1/5 1 1/20 1/10 1/5 1 1/10 1/5 1 1/20 1/10 1/5 1
1 2  3 4 5 6 7 8 9 10 11 12 13 14
For both panel A and B, the enzymatic reactions were carried out as described 
in Figure 6. Both of the enzymatic reaction were for 45 minutes. The concentration 
o f each protein used in this assay is indicated with representing 1 for 160 ng.
A. CCR4-FLAG fusion protein does not degrade dsDNA. The 5’-labeled input 
dsDNA is marked at the right.
B. CCR4-fiision protein did not degrade 5’- labeled RNA with 3 1 0  C.
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Figure 9. The CCR4 protein is a poly (A) exoribonuclease.
Figure 9
Blank CCR4-FLAG ccr4-1-FLAG
0 5 10 20 30 0 5 10 20 30 0 5 10 20 30 Min
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
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Figure 9B RNA-3'-20A
Blank CCR4-FLAG ccr4-1-FLAG ccr4-(-1,-4)-FLAG ccr4
0 5 10 20 30 60 0 510  203060  0 5 10 20 30 60
19 20 21 22 23 24 25 26 27 28 29 30
A and B. Time course o f CCR4-FLAG fusion protein degradation of 5’- 
labeled RNA with 3’-20A substrate. In panel A, all the protein concentrations were at 
80 ng. In panel B, the protein concentration was about 160 ng, the same concentration 
used in the ssDNA enzymatic assay.
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X  CCR4-FLAG ccr4-1-FLAG ccr4-(-1 ,-4)-FLAG ccr4 *  CCR4-FLAG g g
3  1/1001/10 1 1/1001/10 1 1/100 1/10 1 1/1001/10 1 m 1/1001/101 1 1
A60- 
A0-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 1819
Two internally [a -  P] UTP labeled capped mRNA were used by this assay.
One contains 60A at its 3’- end as indicated as A60 in the Figure. The other is without
any A at its 3’- end as marked as A0. The protein concentration is represented in the 
Figure, as 1 equals 160 ng. The total incubation time was 30 minutes.
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Discussion
CCR4 is a ssDNA and RNA binding protein
In this study, using a highly purified GST-CCR4 (C-terminal domain) fusion 
protein, we showed that the CCR4 protein is capable o f binding ssDNA and RNA. 
These ssDNA/RNA interactions were not DNA/RNA sequence dependent. On 
contrast to these results, we were not able to detect the binding of CCR4 to dsDNA. 
We also did not detect any interaction o f CCR4 with dsDNA by performing chromatin 
immunoprecipitation using anti-CCR4 antibody (Data not shown; P. Komamistsky 
personal communication). These results suggested that the CCR4 protein might only 
recognize single stranded poly-nucleotides as its substrates. Although all the catalytic 
motifs o f the C-terminal domain o f CCR4 display strong homology to the Exo III and 
HAP1 (APE1) AP endonuclease domains, there are amino acid variations spread 
throughout all of the C-terminal domain. It is possible that the substrate specificity 
lies in those other amino acids. We have identified several additional protein motifs, 
which are extremely high conserved between CCR4 and its homologs in other 
eukaryotes, but which are not present in Exo III or HAP1 (APE1). These conserved 
protein motifs regions may contact DNA/RNA, and thereby determine the substrate 
specificity o f CCR4. Additional experiments to mutate these motifs and perform gel 
mobility shift assays to analyze DNA binding will clarify these issues.
Mutating the catalytic amino acids (ccr4-l, ccr4-2, ccr4-3, ccr4-4) did not 
affect DNA/RNA binding capability as compared to the wild-type CCR4 protein. This 
is expected since these catalytic residues do not directly contact the DNA/RNA 
substrate or stabilize the protein and DNA/RNA interaction. It is proposed, in the
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APE1 case, that three APE1 helical residues (Arg73, Ala74, and Lys78), Tyrl28 and 
Glyl27, Met270 contact the DNA substrate and stabilize the tight packing o f the 
DNA-protein ternary structure o f the active site pocket. The catalytic amino acids 
then initiate the enzymatic reactions (Mol et al 2000; Nguyen et al 2000). Direct 
biochemical study also showed that the mutations in the catalytic residues o f  Exo III 
and APE1 did not interfere with DNA/RNA association (Barzilay et al 1995; Gorman 
et al 1997; Nguyen et al 2000).
Based on kinetic and binding studies o f HAP 1 (APE1), and its mutants, the 
enzymatic reaction pathway can be summarized in the following steps: APE1 binds 
specifically to the DNA substrate in the absence o f Mg2+ to form a stable intermediate 
complex (Wilson et al 1997; Nguyen et al 2000). This complex is then converted to a 
catalytically competent complex in the presence o f Mg2+ (Lucas et al 1999). No large 
conformational changes with the DNA occur upon metal coordination. Catalysis 
subsequently occurs, resulting in cleavage of the phosphodiester bond. From this 
model, we may explain that GST-ccr4-l mutants repeatedly displayed stronger 
interaction with the ssDNA. GST-ccr4-l mutant protein may not be able to coordinate 
the metal Mg2+ ion, and thus with less Mg2+, it can form a more stable intermediate 
DNA-protein complex. We tended to observe stronger DNA-protein interaction bands 
on gel mobility shift assays with GST-ccr4-l than with GST-CCR4.
The CCR4 protein is a 3’-5’ poly (A) exonuclease and exoribonuclease
Several lines o f  evidences indicated that the CCR4 protein encodes 3’-5’ poly 
(A) exonuclease and exoribonuclease activities. First, database searches with the C-
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terminal region of CCR4 showed that it is homologous with Exonuclease III and 
APE1 (HAP1) o f the apurinic endonuclease family. The CCR4 homology extends to 
all five highly conserved catalytic and metal binding motifs in this family o f proteins. 
Second, mutation o f the key catalytic Mg2+ binding residue (E556A) o f the CCR4 
protein completely abrogated CCR4 function in vivo. Mutation o f the histidine 
(H 818A) putatively involved in helping nucleophilic attack also significantly reduced 
CCR4 function. Third, the GST-CCR4 (C-terminal domain) fusion protein displayed 
exonuclease and 5’-phosphatase activities. These activities were abolished where the 
GST-ccr4-l was analyzed. Fourth, and most importantly, full length CCR4-FLAG 
fusion protein displays poly (A) ssDNA exonuclease and exoribonuclease activities. 
Also, the RNA substrate was a more preferred substrate than the ssDNA substrate 
(Figure 9). These observations agree with the previous observation that CCR4 and 
CAF1 protein are the major components of the mRNA deadenylase.
Our results establish that the CCR4 protein is the catalytic subunit o f  this 
enzyme complex. Immunoprecipitation analysis indicated that all the CCR4 
associated proteins bind to the CCR4-FLAG beads. However, Superose 6 gel 
filtration chromatographic analysis showed that most o f the CCR4-FLAG proteins 
remain as a monomer in the whole yeast extracts (Data not shown). These data may 
suggest that the CCR4 protein is sufficient by itself to catalyze the RNA/DNA 
enzymatic reactions. Since the C-terminal portion o f CCR4 alone displays 5’ 
phosphatase activity and some exonuclease activity, it is likely that the remainder of 
the CCR4-NOT complex is not required for at least these activities. Since we did not 
observe processive 3’ exonuclease activity with this C-terminal CCR4 fragment, it
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remains unclear what the role of the CCR4-NOT complex is in this activity. However, 
we have not ruled out the possibility that the CCR4 associated proteins may help to 
increase the substrate specificity o f this enzymatic reaction, or even increase the 
enzymatic reaction rate. For instance, the yeast CAF1 protein shares homology to the 
3’ exonuclease RNase D family (Moser et al 1997), although it is missing key amino 
acids required for catalysis. While it may not be catalytically active, it may help to 
stabilize the RNA/DNA-protein intermediates required in CCR4 enzymatic function. 
(Preliminary data showed that GST-CAF1 binds to ssDNA.) NOT4 contains a 
putative RNA binding motif. Deletion or mutation o f the RNA binding motif o f 
NOT4 inactivated NOT4 in vivo (Data not shown). Further investigations are 
obviously required to determine their functional roles in CCR4 enzymatic activity.
The CCR4 protein also specifically recognized the 3’ A as its substrate. 
Interestingly, one member o f this Mg2+ dependent Exo III/ HAP1 (APE1) family, Line 
LI endonuclease also shares a poly (A) substrate preference like that of CCR4 protein. 
Human LI elements are highly abundant poly (A) (non-LTR) retroviral elements 
whose second open reading frame (ORF2) encodes a reverse transcriptase (RT). The 
endonuclease (EN) domain at the N-terminal of ORF2 shows homology to AP 
endonuclease. However, LI EN protein was shown to display nicking endonuclease 
activities on native and supercoiled DNA that was not specific for AP-DNA 
substrates. The cleavage hot spots on the DNA substrate are one or more purines just 
3’ to the site o f cleavage, and these often involve short runs o f As (Feng et al 1996; 
Cost et al 2001). Although LI EN and CCR4 lack the AP recognizing sequences in 
their ternary structure as found in the Exo EH and APE1 protein, the structural
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resemblence may still demonstrate their substrate preferences. In the ternary structure, 
the AP sites recognized by AP nuclease are severely distorted, with the helical axis 
kinked at about 5°A (Mol et al 2000). The base to be modified is flipped or rotated 
completely out o f the double helical structure so that the base can be accessed by the 
catalytic sites o f the enzyme. The same mechanism is utilized by the DNA 
modification methylase (Klimasauskas et al 1994; Robert er al 1994). The poly (A) 
ssDNA or RNA may also be easily flipped or bent as it binds to the protein, and may 
represent the same structure as the apurinic site o f DNA. The substrate preference 
suggests that this AP endonuclease family may share certain aspects in its recognition 
of the substrate.
Implication of enzymatic function of CCR4 in the regulation of gene expression
The identification of CCR4 as a DNA/RNA nuclease greatly helps us to 
understand its physiological roles in gene expression. The CCR4-NOT proteins have 
been found to affect gene expressions both positively and negatively (Collart and 
Struhl 1993. 1994; Denis 1984; Denis and Malvar 1990; Liu et al 1998). The first 
direct evidence o f CCR4 enzymatic activity linked to its physiological role in vivo was 
proposed by Tucker et al (2000) that CCR4 and CAF1 protein are components o f the 
major mRNA deadenylase in S. cerevisiae. The mRNA deadenylation by CCR4 and 
CAF1 would initiate the mRNA turn-over pathway, and thus reduce the level o f 
mRNA. The deadenylation of a mRNA transcript also can lead to a decreased rate o f 
translation (reviews in Sachs et al 1997). This negative regulatory effect o f CCR4 in
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term o f deadenylation may therefore explain much of the data from whole genome 
microarray analysis, which showed that CCR4 affects the expression of about 800 
genes by at least 1.8 fold (C. Denis, personal communication.). For example, the 
expression of a number o f cell wall genes increases in a ccr4 background. Whether 
these genes are being affected at the level o f mRNA degradation will have to await 
further analysis.
However, these repressive effects may not explain all the regulatory functions 
of the CCR4 protein in vivo. An alternative model for the enzymatic function of 
CCR4 protein in vivo is proposed here: the CCR4 protein is a nuclear transcription 
factor, which regulates the transcription initiation, elongation, termination related to 
pre-mRNA degradation. A couple o f  lines of evidence support this model. The CCR4 
protein is required for activation of ADH2 expression under non-fermentative growth 
condition (Denis 1984). Also, ccr4 affects both CYC! and the CYCl-lacZ reporter 
gene expression, suggesting a role in the control o f CYC 1 initiation (Liu et al 1998; 
Chang et al 1999). Moreover, ccr4 has been shown to not affect the rate of 
degradation of the ADH2 gene (Y. Cui personal communication). The CCR4 protein 
appears to function as the transcription activator in these processes. One possible role 
for the CCR4 enzyme in initiation is that it helps the transcription preinitiation 
machinery to clear the promoter. CCR4, together with TFIIH and TFIIE may help 
push RNA polymerase II holoenzyme out o f the abortive mode at certain promoters. 
The abortive mode occurs when RNA pol II produces catalytic amounts o f short RNA 
molecules as RNA synthesis primers (up to nine nucleotides) (Holstege et al 1996, 
1997; Maclune et al 1985). The CCR4 protein may help degrade the short RNA
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transcripts and therefore promote increased initiation. An in vitro transcription run-on 
assay would help determine the CCR4 enzymatic role in transcription initiation, 
especially in promoter clearance. This model would suggest that CCR4 has no 
preference for RNA substrates
CCR4 and CAF1 have also been found to reduce the formation o f full-length 
ADH2-lacZ and FKSl-lacZ mRNA by blocking expression of the 3’-end of the genes. 
The lacZ gene when expressed in yeast has been shown to contain cryptic poly (A) 
sites (Russnak et al 1995). It is possible that CCR4 aids the establishment or 
stabilization o f paused or arrested RNA pol II elongation complexes, which when 
occurring proximal to lacZ cryptic poly (A) sites results in increased cleavage of 
RNA. CCR4 may help degrade the nascent immature pre-mRNA when the RNA pol 
II elongation complex must backslide or even abort transcription elongation.
As for termination-related mRNA degradation, recently a nuclear pathway that 
rapidly degrades unspliced pre-mRNA in yeast had been identified (Bonsquet- 
Antonelli et al 2000; Lewis et al 2000). This involves a two mechanisms of 3’-5 
degradation by the exosome complex and 5’-3’ degradation by the exonuclease Patl.
It is possible that the CCR4 protein aids the components of the exosome in regulating 
some genes, and thus serve as a deadenylase in the nucleus. This may even involve 
transcriptional coupled pre-mRNA deadenylation process. It is quite reasonable to 
believe that this process is probably efficient in deadenylating nuclear RNAs, and 
recycling the transcription machinery and nucleotides into the next round of 
transcription. Detailed examination of the exosome complex will provide important 
information regarding CCR4 roles in this process.
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Last, the enzymatic function of the CCR4 protein may suggest its roles in 
recombination. The ccr4A mutant had been identified as sensitive to UV irradiation, 
and ccr4A and rad52A double mutants have synthetic effects on lost of phenotypes 
(Liu et al 1998; C. Denis, personal communication). The presence o f CCR4 in the 
PAF1-RNA polymerase II complex also suggests a connection between transcription 
and recombination, since several components o f the PAF1 complex affect 
recombination (Chang et al 1999). Whether CCR4 protein catalyzes degradation o f 
ssDNA in the recombination process should be further analyzed. However, it should 
be kept in mind that the effect o f CCR4 protein on recombination may be indirect and 
accomplished through its effects on the expression of factors required for 
recombination.
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Summary
The major pathw ays of mRNA turnover in eukaryotes 
initiate with shortening of the  poly(A) tail. We demon­
s tra te  by several criteria tha t CCR4 and CAF1 encode 
critical com ponents of the m ajor cytoplasmic dead­
enylase in yeast. First, both Ccr4p and C aflp  are re­
quired for normal mRNA deadenylation in vivo. Sec­
ond, both proteins localize to  the cytoplasm. Third, 
purification of C aflp  copurifies with a Ccr4p-depen- 
den t poly(A)-specific exonuclease activity. We also 
provide evidence th a t the  Pan2p/Pan3p nuclease com­
plex encodes the predom inant alternative deadenyl­
ase . These results, and  previous work on Pan2p/ 
Pan3p, define the mRNA deadenylases in y e a s t The 
strong conservation of Ccr4p, Caflp, Pan2p, and 
Pan3p indicates th a t they will function a s  deadenyl­
a se s  in o ther eukaryotes. Interestingly, because Ccr4p 
and C aflp  interact with transcription factors, these 
results suggest an unexpected link betw een mRNA 
synthesis and turnover.
Introduction
The process and regulation of mRNAtumoveris a  funda­
mental aspect of gene regulation. Two general pathways 
by which eukaryotic polyadenylated mRNAs can be de­
graded are now known (reviewed in Beelman and Par­
ker, 1995). In each case, degradation of the transcripts 
is initiated by shortening of the poly(A) tail a t the 3 ' end 
of the transcript. This process, referred to a s  deadenyl­
ation, leads to a  deadenylated transcript that is primarily 
a  substrate for mRNA decapping, which exposes the 
mRNA to rapid 5' to 3 ' exonucleolytic digestion (Muhlrad 
and Parker, 1992; Decker and Parker, 1993; Hsu and 
Stevens, 1993; Muhlrad etal., 1994,1995). Alternatively, 
transcripts can be degraded in a  3 ' to 5' direction follow­
ing deadenylation (Muhlrad e t at., 1995; Anderson and 
Parker, 1998).
Deadenylation is a  critical step  in the modulation of 
mRNA function and stability for several reasons. First, 
for both of the general decay pathways in yeast, dead­
enylation is required before degradation of the mRNA
*To whom correspondence should be addressed (e-mail: rrparker©
u.arizona.edu).
body (Muhlrad and Parker, 1992; Decker and Parker, 
1993; Hsu and Stevens, 1993; Muhlrad et al., 1994,1995). 
Second, deadenylation has been shown to be the initial 
step for mRNA turnover in a variety of eukaryotes for a  
number of transcripts (e.g., Wilson and Treisman, 1988; 
Shyu et al., 1991; Couttet et al., 1997). Third, individual 
mRNAs can have very different rates of deadenylation, 
and these variations can lead to overall differences in 
mRNA decay rates (e.g., Decker and Parker, 1993; 
Wreden et al., 1997; Grosset et al., 2000). Moreover, 
many known sequence elements that promote mRNA 
turnover do so, at least in part, by promoting deadenyl­
ation (e.g., Wilson and Treisman, 1988; Shyu e t al., 1991; 
Muhlrad and Parker, 1992; Caponigro and Parker, 1996). 
Finally, because the presence of a  3 ' poly(A) tall can 
enhance translation initiation, deadenylation of a  tran­
script can lead also to a decreased rate of translation 
(reviewed in Sachs et al., 1997). The regulation of mRNA 
translation by both deadenylation and re-adenylation is 
a  common strategy in early development wherein gene 
expression requires modulation by a variety of posttran- 
scriptional mechanisms (for review, see  Gray and Wick- 
ens, 1998).
An important step in understanding the mechanisms 
and control of deadenylation will be the identification 
and analysis of the mRNA deadenylases. Two possible 
deadenylases have been characterized previously. A 
poly(A)-specific exoribonuclease, referred to as PARN, 
was identified from calf thymus (Komerand Wahle, 1997) 
and subsequently shown to be a member of the RNaseD 
family of exonucleases (Komer et al., 1998). Immunode- 
pletion or antibody inactivation experiments demon­
strated that PARN is required for deadenylation during 
oocyte maturation inXenopus (Komeretal., 1998; Dehlin 
et al., 2000), and for deadenylation in HeLa cell extracts 
(Martinez et al., 2000). Although there are PARN homo­
logs in other mammals, the genomes of Saccharomyces 
cerevisae and Drosophila melanogaster do not appear 
to contain a  similar enzyme. In yeast, a  poly(A) nuclease, 
referred to a s  PAN, has been identified biochemically 
and shown to be  an enzyme consisting of the Pan2 and 
Pan3 proteins (Lowell et al., 1992; Boeck e t al., 1996; 
Brown etal., 1996). The Pan2p subunit is likely the cata­
lytic subunit since this protein is a  member of the 
RNaseD family of 3 ' to 5' exonucleases (Moser et al.,
1997). However, pan2£t and pan3& yeast strains show 
minimal effects on deadenylation in vivo (Boeck e t al.,
1996; Brown et al., 1996) and it has been suggested that 
the Pan2p/Pan3p exonuclease may play a  role in initial 
trimming of the nuclear poly(A) tail (Brown and Sachs,
1998). These reports suggest that there are likely to be 
additional mRNA deadenylases.
Three observations led us to consider that the Ccr4 and 
Cafl proteins might encode an mRNA deadenylase in 
y east First, both Ccr4p and its associated factor, Caflp, 
have nuclease domains. Ccr4p belongs to a  magnesium- 
dependent endonuclease-related family of nucleases 
(Dlakic, 2000; C. D., unpublished observations). Caflp 
homologs in mammalian cells and C. elagans are mem­
bers of the RNaseD family of 3 ' to 5 ' exonucleases, and
117
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the yeast Caf1 p is related, albeit missing som e residues 
thought to be  critical for exonuclease function (Moser 
et al., 1997). Second, ccr4A and caff A strains show 
increases and decreases in the steady state levels of 
mRNAs suggesting that these proteins somehow affect 
mRNA metabolism (e.g., Denis and Malvar, 1990; Sakai 
et al., 1992), although som e of these  effects may be at 
the level of transcriptional initiation (Denis and Malvar, 
1990; Uu et al., 1998; Chang e t al., 1999; Y. Cui and 
C. D., unpublished observations). Third, both Ccr4p and 
C aflp show interactions with proteins functioning in 
mRNA degradation. For example, C aflp coimmuno- 
precipitates with Dhhlp (Hata e t al., 1998), which is a  
component of an mRNA decapping complex (J. Colter, 
M. T., and R. P., unpublished observations). Moreover, 
overexpression of Dhhlp suppresses sam e of the growth 
phenotypes of the ccr4A and caff A strains (Hata et at.,
1998). Similarly, overexpression of MPT5/PUF5, a  mem­
ber of the Put family of proteins that regulate mRNA 
deadenylation (Olivas and  Parker, 2000), can partially 
suppress growth phenotypes associated with caff A mu­
tants (Hata e t al., 1998). Together, these observations 
suggested that the Ccr4p/Caf1 p complex might be in­
volved in mRNA turnover.
In this study, w e examined the role of Ccr4p and Caf1 p 
in mRNA turnover. We determined that both CCR4 and 
CAF1 gene products are required for normal rates of 
deadenylation in vivo. We demonstrate that both Ccr4p 
and Caflp localize primarily to the cytoplasm where 
mRNA turnover occurs. Finally, we show that the Caflp 
copurifies with deadenylase activity in vitro and does 
so  in a Ccr4p-dependent manner. These observations 
indicate that the Ccr4p/Caf1 p complex encodes the pri­
mary cytoplasmic deadenylase in y e a s t These data also 
imply that the Ccr4p and Cafl p homologs that exist in 
other organisms will serve similar roles as  cytoplasmic 
deadenylases.
Results
Ccr4p and  C aflp  Are Required for Normal 
R ates o f mRNA Turnover
To examine If Ccr4p and C aflp had a role in mRNA 
turnover, we first determined if they affected the half- 
lives of yeast mRNAs. We examined the decay of the 
MFA2pG and PGKIpG reporter transcripts (Decker and 
Parker, 1993). These transcripts are under the control 
of the GAL1 UAS, thereby allowing the measurement of 
decay rates following the addition of glucose to repress 
transcription. In addition, these mRNAs contain a poly(G) 
tract in their 3’ UTR that inhibits 5 ' to 3 ' exonuclease 
digestion following decapping, allowing the detection 
of a decay intermediate th a t extends from the 5 ' side 
of the poly(G) tract to the 3 ' end of the mRNA.
We observed that the MFA2pG mRNA w as stabilized 
approximately 2- to 3-fold in ccr4A and caff A strains 
com pared to  wild type (Figure 1). In addition, the levels 
of the decay intermediate were reduced consistent with 
a  block a t  or before the S' to 3 ' decay of the transcript 
(Figure 1). We also observed that the PGKIpG, GAL.1, 
GAL7, and GAL.10 mRNAs were more stable in ccr4A and 
cafl A strains (Table 1) indicating that Ccr4p and Cafl p are 
required for the turnover of a  number of yeast mRNAs.
wild-type
<r 2 c  e  v  t<r i?  a r  a r  4<r o r
ccr4A
caflA
Figure 1. Measurement of the Decay Rate o f the MFA2pG mRNA 
Shown are transcriptional shutoff analyses o f wild-type, ccr4A, and 
caff A strains. Here, and in other figures, the full-length (FL) mRNA 
and decay fragment (Frag.) Is Indicated at the left. Time points are 
minutes after the addition of glucose.
Ccr4p and C aflp  Are Required 
for mRNA Deadenylation
To understand the role of Ccr4p and Caflp in mRNA 
turnover, we determined whether the  ccr4A and/or 
caff A strains were altered in deadenylation, decapping, 
or 5 ' to 3 ' exonuclease digestion. To address this ques­
tion, we analyzed the decay of the  MFA2pG and 
PGKIpG mRNAs in the ccr4A and caff A backgrounds 
by a  transcriptional pulse chase (Decker and Parker, 
1993). In this experiment, we utilize the carbon source 
regulation of the GAL UAS to rapidly induce and then 
repress transcription of these reporter mRNAs. This pro­
duces a  pool of newly transcribed mRNAs whose m etab­
olism can be followed over time to  observe deadenyl­
ation and subsequent decay of the mRNA.
Comparison of transcriptional pulse chases for the 
MFA2pG and PGKIpG mRNAs in ccr4A and caff A 
strains identified two differences from wild-type strains 
(Figure 2). First, in both ccr4A and caffA strains, the 
rates of deadenylation for MFA2pG and PGK1 pG were 
impaired. The poly(A) tail of the MFA2pG mRNA in wild- 
type shortened a t a  rate of approximately 13 nucleotides 
per minute, with a significant percentage of the popula­
tion reaching an oligo(A) length of 10-12 nucleotides in 
4 to 6 min (Figure 2A). In contrast, in both the ccr4A and 
caffA mutant strains, the MFA2pG deadenylated at a  
rate of approximately 2-3 nucleotides per minute (Fig-
Table 1. mRNA Half-Lives in Wild-Type, ccr4A, and caffA 
Strains
mRNA WT ccr4A caff A
MFA2pG 4.5' 10' 15’
PGKIpG 24' 38' 49'
GAL1 7.0' 24' 20'
GAL7 12' 27’ ND
GAL10 7.0' 18’ ND
Half-lives are based on multiple determinations and typically vary 
by less than 10% between individual experiments.
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Rgure 2. Transcriptional Pulse-Chase Anal­
ysis of the MFA2pG and PGK1 pG Transcripts 
Shown are polyacrylamide Northern gels ex­
amining the decay of MFA2pG (A, B, and C) 
and PGK1 pG (D, E, and F) in wild-type, ccr4A, 
and ca fl A strains. Numbers above the lanes 
ara minutes after transcriptional repression 
by the addition of glucose following an 8 min 
induction of transcription (see Decker and 
Parker, 1993). The 0 and 120 min time points 
were treated with RNaseH and oligo(dT) 1° 
indicate the position o f the deadenylated 
mRNA. Here, and in all subsequent figures, 
poly(A) tail lengths were determined by com­
parison of bands to size standards and the 
poly(A)-minus mRNA species generated by 
cleavage of RNaseH and oligo(dT) (data not 
shown). Here, and in other figures, to allow 
for size resolution of the poly(A) tail, the 3' 
319-nucleotides of the 1.4-kb PGK1 pG mRNA 
were cleaved by hybridizing to oRP70 fol­
lowed by cleavage with RNaseH priorto load­
ing on the gel.
aT caflA  o t
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ures 2B and 2C). In this strain background, the MFA2pG 
reporter is not fully repressed by glucose and, for this 
reason, there is som e residual transcription. This is the 
reason for the persistence of a distributed population 
of adenylated MFA2pG transcripts in wild-type cells. We 
also observed defects in deadenylation for the PGKIpG 
mRNA; however, the difference in rates w as less dra­
matic. In wild-type strains, PGK1 pG deadenylated at an 
approximate rate of 2-3 nucleotides per minute (Rgure 
2D). In ccr4A strains, the deadenylation rate of the 
PGK1 pG mRNA was approximately 1 nucleotide per min­
u te  (Rgure 2E). Interestingly, the caffA had only a  mod­
e s t  effect on the  deadenylation rate of the PGKIpG 
mRNA (Rgure 2F). This suggests that the change in half- 
life of the PGK1 pG mRNA in the cafl A strain w as due 
to  a  difference in the  extent of deadenylation (see be­
low). The difference in deadenylation rates between 
ccr4A and caff A mutant strains also implies tha t Ccr4p 
has a  more central role in deadenylation (see below).
A second difference In the ccr4A and caffA strains 
w as that the deadenylation of the MFA2pG and PGK1 pG
mRNAs was incomplete. In wild-type strains, the poly(A) 
tail shortens to  an oligo(A) length of 10-12 nucleotides 
before the mRNA can become a  substrate for decapping 
and subsequent 5 ' to 3 ' degradation (Decker and Parker, 
1993). The MFA2pG and PGKIpG mRNAs at late time 
points in the ccr4A and caffA strains had poly(A) tails 
slightly longer than observed in wild type (Rgure 2). To 
measure this difference in the endpoint of deadenylation 
more clearly, we measured the distribution of poly(A) 
tails on MFA2pG and PGK1 pG mRNA populations under 
steady state conditions from wild-type, ccr4A, and 
caffA (Rgures 3A and 3B). Treatment of sam ples with 
RNase H and oligo(dT) indicated tha t the size differences 
were due to the length of the poly(A) tail (Rgure 3, lanes 
8 to 13). Wild-type MFA2pG and PGKIpG mRNAs have 
a  steady state poly(A) distribution from 75 to approxi­
mately 10-12 adenosine residues (Rgure 3, lane 2; 
Decker and Parker, 1993). In ccr4A strains, the shortest 
poly(A) tails observed for both MFA2pG and PGKIpG 
were 20-26 adenosines (Rgure 3, lane 3). Similarly, in 
caffA strains, the shortest poly(A) tails observed for
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Rgure 3. Comparison of Deadenylation End Points 
Shown are the deadenylation end points for MFA2pG (A), PGK1 pG 
(B), GAL10 (C), and RPL41 a (D) transcripts In wild-type, ccr4X cafIX  
ccr4Xlcaf1 X  pan2x, and ccr4X/pan2x strains. Steady state mRNA 
samples were resolved on 6% polyacryiamid e/8 M urea Northern 
gels either with o r without removal of poly(A) tails with RNaseH and 
oligo(dT) (as Indicated). To allow for size resolution of the poly(A) 
tall, the 3' 202-nucleodldes of the 2.2-kb GAL10 mRNA were cleaved 
by hybridizing to oRP97 followed by cleavage with RNaseH prior to 
loading on the gel.
both MFA2pG and PGKIpG measured slightly shorter 
a t  14-20 adenosines (Rgure 3, lane 4). We also observed 
that in a  ccr4A/caf1 X double mutant, the end point of 
deadenylation w as the sam e as in a  ccr4A strain (Rgure 
3, lane 5), indicating th a tthe  ccr4X mutant had a  stronger 
effect on the extent of deadenylation than the cafIX 
mutation. We observed similar effects of the ccr4X and 
cafl A on the GAL10 (Rgure 3C), RPL41a (Rgure 3D), and 
MRPL27 (data not shown) mRNAs. These observations 
indicate tha t the  CCR4 and CAF1 gene products affect 





Rgure 4. Localization of Ccr4p and Cafl p by Indirect Immunofluo­
rescence
Strains expressing myc-tagged Ccr4p (yRP1621), myc-tagged 
Caflp (yRP1622), or wild-type control (yRP841) were stained with 
anti-myc antibodies and anti-mouse (FITC) 2° antibody and DAPI 
as indicated.
Ccr4p and C aflp  Are Present in the Cytoplasm 
The above experiments indicated that the Ccr4p and 
C aflp had a  role in cytoplasmic deadenylation. While 
prior work has suggested a  nuclear, transcriptional role 
for these proteins, this may not be their sole function. 
If Ccr4p and C aflp are directly involved in deadenyl­
ation, a t least a  portion of these polypeptides should 
be present within the cytoplasm. To determine the sub- 
cellular distribution of Ccr4p and Cafl p, we constructed 
chromosomal CCR4 and CAF1 genes with multiple Myc 
epitopes on their C termini and localized these proteins 
by immunofluorsecence (see Experimental Procedures). 
These epitope-tagged proteins were functional as a s ­
sessed  by both growth and mRNA turnover phenotypes 
(data not shown). Importantly, detection of the fusion 
protein by immunofluorescence indicated that the ma­
jority of Ccr4p-myc and Caf1p-myc are present in the 
cytoplasm (Rgure 4). These data  are consistent with the 
hypothesis that Ccr4p and Cafl p have a  direct role in 
cytoplasmic deadenylation.
C aflp  Copurifies with a  Ccr4p-Dependent, 
poly(A)-Specific Nuclease Activity 
Since both Ccr4p and Caflp were required for deade­
nylation in vivo, localized to the cytoplasm, and had 
significant homology to known nucleases, we hypothe­
sized that a  complex containing minimally Ccr4p and 
Caflp would constitute the mRNA deadenylase. This 
possibility is supported by prior work demonstrating 
that Ccr4p and Cafl p interact (Sakai et al., 1992; Draper 
et al., 1995) and can be copurified along with several 
other proteins (Uu e t al., 1997; Liu e t al., 1998; Ober- 
holzerand Collart, 1998). Given this, we purified a func­
tional RAG-Caf1 fusion protein from a  wild-type strain 
under conditions that would copurify endogenous Ccr4p. 
Based on silver staining and Western analysis, this prep­
aration contained FLAG-Caf1 p, Ccr4p, and several addi­
tional proteins (data not shown, see  Discussion).
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Rgure 5. FLAG-Caflp Copurities with Dead­
enylase Activity
Analysis of deadenylation activity In FLAG- 
Caflp elution from wild-type (A), and from 
ccr4\ (B) strains on a capped, polyadeny- 
lated substrata, and analysis o f nuclease ac­
tivity in FLAG-Caflp elution fractions from 
wild-type on capped, nonadenylated sub­
strate (C). Numbers above the lanes Indicate 
time points taken after addition of substrate 
to the reaction. The arrow in panel (A) repre­
sents the fully deadenylated form of the sub­
strate based on migration of substrate prior 
to poly(A) addition (data not shown). The ‘  
indicates the position of the radtolableled 
phosphate. Deadenylation activity of FLAG- 
Caflp elution fractions from wild-type on 
substrate 3’ end labeled with 32p adenosine 
(D). The products of the reaction were sepa­
rated by PEI-cellulose TLC. Numbers above 
the lanes Indicate time points taken after ad­
dition of substrate to the reaction. The migra­
tion of cold 5' AMP standard is indicated on 
the left.
Purified FLAG-Caf1 p/Ccr4p and associated proteins 
were then assayed  for their ability to  deadenylate an 
mRNA substrate in vitro. A 5' labeled, capped mRNA, 
synthesized in vitro with a  49-nucleotide body and a 
poly(A) tail length of approximately 20 to 40 adenosines 
w as incubated with purified FLAG-Caflp extracts and 
analyzed a t various times on 6% polyacrylamide gels. 
We observed that shorter species of the input RNA ap­
peared overtime. Since the substrate is 5' labeled, these 
shorter species represent trimming from the 3' end. We 
also observed that a new species accumulated of the 
correct length to  represent a fully deadenylated sub­
strate (Rgure 5A). These conclusions were also sup­
ported by the observation that removal of the poly(A) 
tail with oligo(dT) and RNaseH shortens the input mRNA 
as expected but does not shorten the product produced 
in vitro (data not shown). The accumulation of the dead­
enylated RNA suggested  that the nuclease activity pres­
ent in these fractions is not active on non-poly(A) se­
quences. This conclusion is also supported by the 
observation tha t incubation of the purified FLAG-Caflp 
extracts with a  5 ' labeled, capped mRNA substrate of 
134 nucleotides lacking a  poly(A) tail failed to show any 
significant shortening from the 3' end (Rgure 5C). No 
nuclease activity was observed when we purified a  
FLAG-Cup1 fusion protein from a wild-type strain (data 
not shown) and performed deadenylation assays on 
these extracts. These observations indicate that a  poly(A)- 
specific nuclease copurifies with Cafl p. Two observa­
tions argue tha t this activity is a  3 ' to  5' exonuclease. 
Rrst, the gradual shortening observed over time of the 
polyadenylated substrate is consistent with an exo- 
nucleolytic m ode of action. Second, use of a  substrate 
with a  ” P-labeled adenosine tail led to the release of 
labeled product th a t comigrated with 5' AMP by TLC 
analysis (Rgure SD).
Our analysis indicated that Ccr4p w as required for 
deadenylation in vivo. Moreover, the stronger defects
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in deadenylation seen in a ccr4A strain a s  compared to 
a cafl A strain (see above) suggested that Ccr4p was 
critical to the action of the deadenylase. Given this, we 
determined if the nuclease activity that copurifies with 
Cafl p was dependent on Ccr4p by purifying FLAG-Cafl p 
from a ccr4A strain. In these fractions, we obtain Cafl p, 
and several other associated proteins, but not Ccr4p 
(data not shown, see Discussion). This FLAG-Caflp 
preparation was no longer capable of deadenylation in 
vitro as shown in Rgure SB. This observation indicated 
that Ccr4p is essential for the FLAG-Caf1 p-purified 
deadenylase activity. Together, the above results indi­
cate that the Ccr4p and Caflp are components of the 
major cytoplasmic deadenylase in yeast.
The Pan2p/Pan3p Exonuclease Represents 
a  Second mRNA Deadenylase 
Because ccr4A, c a f1 \  and ccr4blcaf1 A strains show 
residual deadenylation (Rgures 2 and 3), there m ust be 
one or more additional mRNA deadenylases. We hy­
pothesized that either the exosome or the Pan2p/Pan3p 
nuclease carried out this residual deadenylation. The 
exosome is a  multi-subunit enzyme responsible for a 
variety of 3 ' to 5 ' RNA processing and RNA degradation 
events including 3 ' to 5 ' decay of the mRNA body follow­
ing deadenylation (reviewed in van Hoof and Parker,
1999). The Pan2p/Pan3p nuclease is a  poly(A)-specific 
nuclease (PAN) thought to catalyze the initial trimming 
of the nascent poly(A) tail (Brown and Sachs, 1998).
To address whether the exosome or PAN activity was 
responsible for the observed deadenylation in ccr4A 
strains, we first created a  ccr4A/sto'2A double mutant 
strain. Ski2p has been shown previously to be  required 
for cytoplasmic exosome function (Anderson and Par­
ker, 1998) and is a  reasonable marker for the potential 
involvement of the exosome in cytoplasmic functions. 
The ccr4£Jski2& strain grew at the sam e rate as  a  ccr4A 
strain and in vivo mRNA analysis indicated the sam e
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Rgure 6. Transcriptional Pulse-Chase Anal­
yses of the MFA2pG and PGKIpG Tran­
scripts
Shown are polyacrylamide Northern gels of 
transcriptional pulse-chase experiments ex­
amining the decay of MFA2pG (A and B) and 
PGK1 pG (C and 0} In pan2\ and ccr4b/pan2& 
strains. Numbers above the lanes are minutes 
after transcriptional repression by the addi­
tion of glucose following an 8 min Induction of 
transcription (see Decker and Parker, 1993). 
The 0 and 120 min time points were treated 
with RNaseH and oligo(dT) to  indicate the po­
sition of deadenylated mRNA.
defect in deadenylation as  a  ccr4A strain (data not 
shown). This suggested that the cytoplasmic exosome 
w as not responsible forthe residual deadenylation seen 
in ccr4A and caffA strains. However, these results do 
not rule out the formal possibility that the exosom e may 
be involved in the deadenylation process in a  Ski2p- 
independent manner.
To examine the role of the Pan2p/Pan3p nuclease, we 
constructed a  ccr4A/pan2A double mutant. This ccr46J 
p an2 \  double mutant strain grew very slowly suggesting 
som e overlap in function (data not shown). Moreover, 
analysis of the decay of the MFA2pG and PGKIpG 
mRNAs in the ccr4A/pan2A double mutant strain by a  
transcriptional pulse chase showed that the transcripts 
failed to  undergo any significant shortening of their poly(A) 
tails (Rgure 6). This demonstrated that the residual 
deadenylation seen in a  ccr4A strain requires Pan2p. 
The sim plest interpretation of these  observations is that 
PAN Is the only other significant mRNA deadenylase in 
yeast. In addition, it should be noted that the MFA2pG 
and PGK1 pG mRNAs are extremely stable in the ccr4A/ 
pan2& strain since they do not appreciably decay and 
no decay fragments are produced over a  period of two 
hours (Rgure 6). This provides additional evidence that 
deadenylation is a  prerequisite for later steps in mRNA 
turnover.
c c r 4 \  caflA , and ccr4&/pan2A Strains 
Aberrantly Degrade mRNAs Prior 
to  Com plete Deadenylation
Since ccr4A, caffA, and even ccr4Mpan2& strains were 
viable, mRNA turnover m ust be occurring by some 
mechanism . This is based on the  observation th a t inacti­
vation of both decapping and 3 ' to  S' exonucleolytic 
degradation of the mRNA body leads to cell death (An­
derson and Parker, 1998). Several observations indicate 
that strains defective in deadenylation eventually de­
grade their mRNAs by a  slow decapping step that by­
passes the need for deadenylation to an oligo(A) tail 
of 10-12 residues. Rrst, even with defects in poly(A) 
shortening, these strains still produced the poly(G) de­
cay intermediate that normally arises due to  decapping 
and 5' to 3 ' exonuclease digestion (Rgure 3). Second, 
the decay intermediates produced in these  strains had 
substantial poly(A) tails a s  indicated by the size change 
when sam ples were treated with RNaseH and oligo d(T) 
(Figure 3, e.g., lane 3 versus lane 9). We observed that 
the poly(A) tails on the mRNA decay fragment were ap­
proximately 14-22 nucleotides in the ccr4A and caffA 
strains (Rgure 3, lane 3 and 4), and are roughly 70-75 
nucleotides long in the ccr4Mpan2& double mutant 
(Rgure 3, lane 5). This is similar to the shortest poly(A) 
tail length observed on the full-length mRNA and sug­
gests that the decay fragment is being generated after 
partial deadenylation of the mRNA. Rnally, both the 
ccr4A and caffA deletions were synthetically lethal with 
dcp1 A mutants (data not shown). Since DCP1 encodes 
the decapping enzyme, this argues that decapping is 
required for the residual mRNA decay seen in these 
strains. However, we cannot rule outtheform al possibil­
ity that mRNA decay is occurring by a  novel general 
endonucleolytic mechanism.
It is important to  note tha t these decay intermediates 
were produced in the ccr4A, caff A, and ccr4Upan2\ 
strains at significantly lower levels and a t  much later 
time points relative to  wild type (Rgures 2  and 6). This 
provides additional evidence that deadenylation is nor­
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mally a  prerequisite for decapping, although when the 
normal pathway is perturbed, some slow decapping can 
occur on adenylated mRNAs.
Discussion
Ccr4p and C aflp  Are Components 
of a  Cytoplasmic Deadenylase 
Three observations indicate that Ccr4p and C aflp en­
code critical components of the major cytoplasmic 
deadenylase in yeast. First, ccr4A and caffA strains 
show defects in both the rate and extent of deadenyl­
ation for the MFA2pG, PGKIpG, GAL10, and RPL41a 
mRNAs (Figures 2 and 3). Second, based  on indirect 
immunoflourescence, the majority of epitope-tagged 
Ccr4p and Cafl p are present in the cytoplasm, the antic­
ipated subcellular location for the deadenylation pro­
cess  (Rgure 4). Third, FLAG-Caflp copurifies with a 
poly(A)-speciffc deadenylase activity (Rgure 5). This ac­
tivity is independent of the PAN2/PAN3 encoded 3 ' to 
5 ' poly(A) nuclease a s  it copurifies with FLAG-Caflp in 
a  pan2& strain (data not shown). However, this activity 
does require the presence of the Ccr4p since activity is 
absent in purified FLAG-Caflp extracts made from 
ccr4A strains (Rgure 5). These observations demon­
strate that Ccr4p and Cafl p are components of the ma­
jor cytoplasmic mRNA deadenylase in yeast.
An important issue is the actual composition of the 
Ccr4p/Caf1 p deadenylase both in terms of the catalytic 
subunit and other factors involved in deadenylation. 
Ccr4p is the m ost likely candidate for a catalytic subunit 
because the nuclease domain of this protein contains all 
the critical residues predicted to be required for function 
(Dlakic, 2000; C. D„ unpublished observations). Consis­
ten t with this view, the ccr4A has a stronger effect on 
deadenylation than the caffA (Rgures 2 and 3). In addi­
tion, overexpression of Ccr4p can suppress som e of the 
growth defects of a caffA strain (Hata e t al., 1998). In 
contrast, the yeast Caf 1 p is missing amino acids thought 
to be required for catalysis by members of the RNaseD 
family of proteins (Moser et al., 1997). Nevertheless, the 
conservation of the exonuclease motifs in CAF1 homo­
logs in other eukaryotes raises the possibility that the 
Cafl p may also be a  functional nuclease. Interestingly, 
both Ccr4p and Cafl p have been shown to exist in two 
large complexes of ~ 1 .0 MDa and ~ 1 .9 MDa (Liu et al., 
1998; Bai etal., 1999; Lie etal., 2001). The larger complex 
includes the Not proteins (Not1 p to Not5p) and several 
other proteins (Uu e t al., 1998; Bai e t al., 1999). The 
smaller complex contains only Ccr4p, Cafl p, the five 
Not proteins, and two newly identified proteins, Caf40p 
and Caf130p (C. D., unpublished observations). Thus, 
one possibility is that one or both of these  complexes 
constitutes a  deadenylase complex. Additional experi­
ments to  define the catalytic subunit and the diversity 
of proteins tha t can affect deadenylase activity should 
resolve these issues.
An important implication of the work presented here 
is that Ccr4p and Cafl p in other organisms will serve a  
function similar to their yeast counterparts. The Ccr4p 
is a  m em ber of a  broader family of nucleases (Dlakic,
2000). Within this family, true CCR4 orthologs have been 
identified that contain both the leucine-rich repeat do­
main used for binding CAF1 (Bed et al., 1999) and the 
C-terminal putative nuclease domain (Dlakic, 2000; J . C. 
and C. D., unpublished observations). The human (h) 
CCR4 retains its ability to interact with hCAF1 (C. D., 
unpublished observations) and both show multiple inter­
actions with hNOTs suggesting the existence of a human 
CCR4-NOT complex (Albert e t a!., 2000; Y. Chiang and 
C. D„ unpublished observations). This suggests that 
that these protein interactions, and by implication their 
functions, have been conserved in vertebrates. Interest­
ingly, since both the mammalian and yeast CAF1 have 
been implicated in celi-cycle regulation (Liu e t al., 1997; 
Ikematsu et al., 1999; Puisieux and Magaud, 1999), it is 
possible that this control is attained through changes 
in mRNA deadenylation rates of key celi-cycle genes.
Possible Connections betw een Transcription 
and mRNA Turnover
Several previous reports dem onstrate a  clear interaction 
of Ccr4p and Caflp with components of the transcrip­
tion machinery. Rrst, Ccr4p has been identified in a 
Paf1 p-containing RNA polymerase II transcription com­
plex (Chang e t al., 1999). Second, the CCR4-NOT com­
plex components display physical interaction with TFIID 
and components of SAGA (Benson et al., 1998; Badari- 
narayana et al., 2000; Lemaire and Collart, 2000). Third, 
components of the 1.9 mDa CCR4-NOT complex inter­
act with the SRB9-11 proteins of the RNA polymerase 
II holoenzyme (Liu et al., 2001). Fourth, CCR4 and CAF1 
appear to affect the initiation of transcription of several 
genes (Denis and Malvar, 1990; Sakai e t al., 1992; Liu 
et al., 1998; Chang et al., 1999). There are three types 
of explanations for the role of Ccr4p/Caf1 p in both tran­
scription and mRNA degradation. Rrst, the Ccr4p/Caf1p 
complex may function both a s  a  cytoplasmic deade­
nylase and have an alternative role in the initiation of 
transcription. Alternatively, the Ccr4p/Caf1 p may serve 
a similar function in the nucleus deadenylating nuclear 
RNAs, and its association with the transcription machin­
ery is a  consequence of that nuclear deadenylation func­
tion. Rnally, it is possible tha t the connection to  tran­
scriptional machinery represents a  requirement for an 
initial interaction of the Ccr4p/Caf1 p cytoplasmic dead­
enylase with the mRNA in a  cotranscriptional manner. 
In this model, the Ccr4p/Caf1 p deadenylase would re­
quire a  direct interaction with the RNA polymerase II 
holoenzyme to be assembled on to the growing mRNP 
complex. An important goal in future work will be to 
determine the nature of this link between the transcrip­
tional and mRNA degradative machinery.
The Pan2p/Pan3p Ribonuclease Can Function 
as  an mRNA Deadenylase
Our data  indicate that the Pan2p/Pan3p poly(A)-specific 
exonuclease can also function as an mRNA deadenylase 
in vivo. The critical observation is that although ccr4A and 
caffA strains show slow residual deadenylation, a  
ccr4A/pan2A strain is completely blocked for deadenyl­
ation (Rgure 6). Interestingly, prior work has shown that 
the Pan2p/Pan3p deadenylase functions in an initial 
trimming of the poly(A) tail. The critical observations are 
that the initial shortening of nascent poly(A) tails from 
~90 residues to ~55-70 in a  mRNA-specific manner is
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lacking in pan2A and pan3A strains (Brown and Sachs,
1998). We also observed a  longer nascent poly(A) tall 
length in pan2A, and pan2Mccr4\ strains (data not 
shown). This suggests that in the normal metabolism of 
yeast transcripts, the nascent poly(A) tail is trimmed 
by the Pan2p/Pan3p nuclease, and then subsequently 
passed  to the Ccr4p/Caf1 p for the majority of cyto­
plasmic deadenylation. Thus, normal deadenylation re­
quires the sequential action of two different nucleases. 
How, or why, this transition in nucleases occurs is un­
known, but it may coincide with transport of the mRNA 
into the cytoplasm, or changes in mRNP organization, 
perhaps including entry into translation.
Our data indicate that in ccr4A strains, the slow resid­
ual deadenylation that occurs requires Pan2p. One in­
triguing feature of the residual deadenylation catalyzed 
by Pan2p/Pan3p deadenylase is that it appears to stop 
a t the last 20 to  26 adenosines. This stall could be due 
to  the inability of the Pan2p/Pan3p nuclease to shorten 
the mRNA further. Support for this possibility comes from 
observations in vitro wherein PAN requires the po!y(A) 
binding protein (Pablp) as a  cofactor (Lowell et al., 
1992). Since the footprint of a  single bound P ab lp  is 
approximately 25 residues (Sachs e t al., 1987), this 
would suggest tha t the last Pab1 p bound to the poly(A) 
tail might be insufficient to promote Pan2p/Pan3p dead­
enylation in vivo. The observation that the Ccr4p/Caf1p 
complex has the unique ability to process the last phase 
of deadenylation indicates a fundamental difference in 
substrate specificity between these two enzymes.
Implications for Regulation of Deadenylation Rate 
There tire now three distinct enzymes that have been 
shown to function a s  mRNA deadenylases, Ccr4p/Caf1 p 
and Pan2p/Pan3p in yeast and PARN in vertebrates. 
Although there does not appear to be a  direct homolog 
of PARN in yeast, Ccr4p/Caf1p and Pan2p/Pan3p are 
all highly conserved among eukaryotes. This implies that 
eukaryotic cells will contain at least two, and likely multiple, 
distinct deadenylases. This raises the possibility that 
deadenylation of different mRNAs will occur through the 
modulation of different nucleases. Forexample, there may 
be  yeast mRNAs whose primary deadenylation is carried 
out by the Pan2/Pan3 deadenylase. Consistent with the 
view that specific deadenylases may target different 
mRNAs or respond to different regulatory elements, in 
vitro work has suggested  that the enhanced deadenyl­
ation promoted by 3 ' UTR, AU-rich instability elements 
requires PARN (Gao e t al., 2000). Similarly, the rapid 
deadenylation of the  MFA2 mRNA is also promoted by 
specific 3' UTR elements (Muhlrad and Parker, 1992), 
and this rapid deadenylation is lost in ccr4A and caffA 
strains. This indicates that the elements within the MFA2 
3 ' UTR that prom ote deadenylation do so by accelerat­
ing the action of the Ccr4p/Caf1p deadenylase. This 
implies that both PARN as well as  the Ccr4p/Caf1p 
deadenylases in other eukaryotes will be targets of 
mRNA-specific, regulated deadenylation rates. An im­
portant goal of future work will be to determine how the 
rates of specific deadenylases are controlled and how 




All strains used in this study are: trpl ura3-S2 lou2-3, 112 
cupl A::LEU2PM. Strains differ as follows: yRP840 (Hatfield et al., 
1996) MATa hls4-S39, yRP841 (Hatfield et al., 1996) MATa Iys2-201, 
yRP1616 MATa his4-539 ccr4H::NEO, yRP1617 MATa caf1A::URA3. 
yRP1618 MATa his4-S39 ccrthzNEO caf1A-:URA3, yRP1619 MATa 
his4-B39 pan2X-URA3, yRP1620 MATa hls4-S39 ccr4ic:NEO 
pan2teURA3, yRP1621 MATa his4-S39 Iys2-201 CCR4-myc::NEO, 
yRP1622 MATa hls4-S39 CAF1-myc::NEO.
The constructions of the ccr4A, c a f li,  and pan2A were made by 
standard methods of transformation and yeast genetics. All of the 
above gene disruptions were verified by genomic Southern analysis. 
Double mutant strains were obtained by mating combinations of 
single deletion haploid strains, (yRP1618 and yRP1620). myc-tagged 
versions of Ccr4p and Caflp were generated as described in Long- 
tine et al. (1998) and confirmed both by Southern and Western blots.
Plasmids
The FLAG-CAF1 plasmid (pRPI 042) was created by PCR amplifica­
tion of the CAF1 gene from yRP840, placing the FLAG epitope 5' 
of the CAF1 gene, and ligated into the yeast expression vector pG-1 
(Schena et al., 1991) and confirmed by sequencing.
RNA Isolation and Analysis
All procedures with RNA were done as previously described; tran­
scriptional shutoff experiments, RNA isolations and normalization 
(Caponigro et al., 1993), transcriptional pulse-chase experiments 
(with the exception that ail growth media was supplemented with 
1 % sucrose/2% raffinose) (Decker and Parker, 1993), and RNaseH 
reactions (Muhlrad and Parker, 1992).
Localization of Epitope-Tagged Ccr4p and Caflp 
yRP841, yRP1621, and yRP1622 were grown to midlog, fixed, and 
analyzed by standard methods using ami-myc-FITC 9E10 antibody 
(CoVance) at a dilution of 1:200 and goat anti-mouse IgG-FITC 
(Roche) was used at a dilution of 1:300.
In Vitro Deadenylation Assays
FLAG-Caft p proteins were purified from wild-type and ccr4A strains 
(yRP840 and yRP1616) harboring the plasmid pRP1042 following 
similar procedures (Tharun and Parker, 1999). Fractions were ana­
lyzed for activity prior to storage of samplos at -80*C In 20% (v/v) 
glycerol.
To prepare substrato, uncapped RNA was transcribed as pre­
viously described from plasmid pRP802 (LaGrandeur and Parker, 
1998), which was partially digested with Sau3Al, to produce both a 
49- and a 134-nudeotfde transcript The RNAs were capped (La­
Grandeur and Parker, 1998) and poly(A) tails were added to capped 
substrate using Poly(A) polymerase and 650 nM of ATP (Barkoff et 
a l„ 1998). 3' end labeling of substrate was achieved by addition of 
500 nM of a32p ATP to the Poly(A) polymerase reactions.
FLAG-Caf1 p olution fractions were assayed for deadenylation ac­
tivity at 37°C. 100 (d deadenylation reactions contained 70 ^ i of 
FLAG-Caft p elution, 0.01 pmol cap labeled RNA, 20 mM HEPES, 
pH 7.0,1 mM MgOAc, 2 mM spermidine, 1 mM DTT. 0.2 |ig /(il BSA, 
0.2% NP-40, and 1 U/u-l RNasln. 10 id time points were stopped 
with 300 pi of stop mix (20 mM EDTA, 300 mM NaOAc, 3 ng/p.1 
glycogen). Products from the reaction with 3' labeled, poly(A) RNA 
substrates were separated by PEI-cellulose thin layer chromatogra­
phy developed in 0.45 M (NHJrSO,.
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